|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.0169425
|
|
|
RA
|
[NCBI]
|
0.00347584
|
|
|
IS1
|
[NCBI]
|
0.00269936
|
|
|
MAFD1
|
[NCBI]
|
0.00240082
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.0022353
|
|
|
CF
|
[NCBI]
|
0.00201696
|
|
|
SLE
|
[NCBI]
|
0.0018887
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00186113
|
|
|
parkinson disease 12
|
[NCBI]
|
0.00178777
|
|
|
PARK11
|
[NCBI]
|
0.00178777
|
|
|
SCZD3
|
[NCBI]
|
0.00170622
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.00134047
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.00134047
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.00134047
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.00134047
|
|
|
IDDM3
|
[NCBI]
|
0.00134047
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.00134047
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.00134047
|
|
|
amyotrophic lateral sclerosis 6
|
[NCBI]
|
0.00134047
|
|
|
OFC2
|
[NCBI]
|
0.00134047
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.0013285
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.0013285
|
|
|
PSORS2
|
[NCBI]
|
0.00120795
|
|
|
IBD2
|
[NCBI]
|
0.00113002
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.00109594
|
|
|
NIDDM2
|
[NCBI]
|
0.00109594
|
|
|
ICCA
|
[NCBI]
|
0.000929571
|
|
|
MYP3
|
[NCBI]
|
0.000929571
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000929571
|
|
|
SLEB3
|
[NCBI]
|
0.000929571
|
|
|
DFN4
|
[NCBI]
|
0.000929571
|
|
|
acute myelogenous leukemia
|
[NCBI]
|
0.000893408
|
|
|
myopia 9
|
[NCBI]
|
0.000893408
|
|
|
myopia 7
|
[NCBI]
|
0.000893408
|
|
|
convulsions, benign familial infantile, 2
|
[NCBI]
|
0.000893408
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.000893408
|
|
|
FSHMD1B
|
[NCBI]
|
0.000893408
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000893408
|
|
|
SLI2
|
[NCBI]
|
0.000893408
|
|
|
myopia 8
|
[NCBI]
|
0.000893408
|
|
|
SLI1
|
[NCBI]
|
0.000893408
|
|
|
melanoma, cutaneous malignant, 4
|
[NCBI]
|
0.000893408
|
|
|
myopia 5
|
[NCBI]
|
0.000893408
|
|
|
PEE2
|
[NCBI]
|
0.000893408
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.000893408
|
|
|
myopia 14
|
[NCBI]
|
0.000893408
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.000893408
|
|
|
IDDM8
|
[NCBI]
|
0.000893408
|
|
|
GLC1I
|
[NCBI]
|
0.000893408
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.000893408
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.000893408
|
|
|
SLI3
|
[NCBI]
|
0.000893408
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000893408
|
|
|
myopia 10
|
[NCBI]
|
0.000893408
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000893408
|
|
|
restless legs syndrome, susceptibility to, 2
|
[NCBI]
|
0.000893408
|
|
|
IBD7
|
[NCBI]
|
0.000893408
|
|
|
DYX9
|
[NCBI]
|
0.000893408
|
|
|
MNG2
|
[NCBI]
|
0.000893408
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000804541
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000736753
|
|
|
SPG12
|
[NCBI]
|
0.000735554
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000735554
|
|
|
SCA4
|
[NCBI]
|
0.000735554
|
|
|
MRX3
|
[NCBI]
|
0.000735554
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000735554
|
|
|
PARK3
|
[NCBI]
|
0.000616684
|
|
|
HPCX
|
[NCBI]
|
0.000616684
|
|
|
CCA1
|
[NCBI]
|
0.000603122
|
|
|
HMN7A
|
[NCBI]
|
0.000603122
|
|
|
HFM
|
[NCBI]
|
0.000578719
|
|
|
orofacial cleft 4
|
[NCBI]
|
0.000547545
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000547545
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000547545
|
|
|
PSORS3
|
[NCBI]
|
0.000547545
|
|
|
MCOPS4
|
[NCBI]
|
0.000547545
|
|
|
PARK10
|
[NCBI]
|
0.000547545
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000547545
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.000547545
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.000547545
|
|
|
ALS3
|
[NCBI]
|
0.000547545
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.000547545
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000547545
|
|
|
IDDM13
|
[NCBI]
|
0.000547545
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000547545
|
|
|
myopia 6
|
[NCBI]
|
0.000547545
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.000547545
|
|
|
IBD6
|
[NCBI]
|
0.000547545
|
|
|
wilms tumor 4
|
[NCBI]
|
0.000547545
|
|
|
IDDM11
|
[NCBI]
|
0.000547545
|
|
|
IDDM15
|
[NCBI]
|
0.000547545
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000547545
|
|
|
CMD1F
|
[NCBI]
|
0.000547545
|
|
|
IBD9
|
[NCBI]
|
0.000547545
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000503666
|
|
|
SPG5A
|
[NCBI]
|
0.000503666
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000503666
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000503666
|
|
|
MAFD2
|
[NCBI]
|
0.000502139
|
|
|
CRC
|
[NCBI]
|
0.000477653
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.000446586
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.000446586
|
|
|
intelligence quantitative trait locus 2
|
[NCBI]
|
0.000446586
|
|
|
FEB7
|
[NCBI]
|
0.000446586
|
|
|
KTCN2
|
[NCBI]
|
0.000446586
|
|
|
DFNB44
|
[NCBI]
|
0.000446586
|
|
|
retinitis pigmentosa 34
|
[NCBI]
|
0.000446586
|
|
|
KTCN3
|
[NCBI]
|
0.000446586
|
|
|
leukemia, chronic lymphocytic, susceptibility to, 1
|
[NCBI]
|
0.000446586
|
|
|
DSMA2
|
[NCBI]
|
0.000446586
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 3
|
[NCBI]
|
0.000446586
|
|
|
BMND4
|
[NCBI]
|
0.000446586
|
|
|
DFNB66
|
[NCBI]
|
0.000446586
|
|
|
FMTLE
|
[NCBI]
|
0.000446586
|
|
|
DFNB35
|
[NCBI]
|
0.000446586
|
|
|
panic disorder 2
|
[NCBI]
|
0.000446586
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.000446586
|
|
|
AD15
|
[NCBI]
|
0.000446586
|
|
|
acropectorovertebral dysplasia, f-form of
|
[NCBI]
|
0.000446586
|
|
|
GLC1N
|
[NCBI]
|
0.000446586
|
|
|
GLC1K
|
[NCBI]
|
0.000446586
|
|
|
MRT4
|
[NCBI]
|
0.000446586
|
|
|
myoclonic epilepsy, infantile
|
[NCBI]
|
0.000446586
|
|
|
HSCR5
|
[NCBI]
|
0.000446586
|
|
|
MCS
|
[NCBI]
|
0.000446586
|
|
|
MSSD
|
[NCBI]
|
0.000446586
|
|
|
GLC1F
|
[NCBI]
|
0.000446586
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.000446586
|
|
|
foveal hypoplasia and anterior segment dysgenesis
|
[NCBI]
|
0.000446586
|
|
|
stature quantitative trait locus 7
|
[NCBI]
|
0.000446586
|
|
|
IBD8
|
[NCBI]
|
0.000446586
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.000446586
|
|
|
DFNA25
|
[NCBI]
|
0.000446586
|
|
|
GINGF2
|
[NCBI]
|
0.000446586
|
|
|
gallbladder disease 3
|
[NCBI]
|
0.000446586
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000446586
|
|
|
SPG30
|
[NCBI]
|
0.000446586
|
|
|
WM2
|
[NCBI]
|
0.000446586
|
|
|
psoriasis susceptibility 9
|
[NCBI]
|
0.000446586
|
|
|
SQTL2
|
[NCBI]
|
0.000446586
|
|
|
GINGF4
|
[NCBI]
|
0.000446586
|
|
|
MRX73
|
[NCBI]
|
0.000446586
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000446586
|
|
|
MMVP3
|
[NCBI]
|
0.000446586
|
|
|
MRX53
|
[NCBI]
|
0.000446586
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000446586
|
|
|
diamond-blackfan anemia 2
|
[NCBI]
|
0.000446586
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000446586
|
|
|
RP23
|
[NCBI]
|
0.000446586
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000446586
|
|
|
EIG4
|
[NCBI]
|
0.000446586
|
|
|
STHAG5
|
[NCBI]
|
0.000446586
|
|
|
CORDX2
|
[NCBI]
|
0.000446586
|
|
|
STGD4
|
[NCBI]
|
0.000446586
|
|
|
EJM4
|
[NCBI]
|
0.000446586
|
|
|
restless legs syndrome, susceptibility to, 5
|
[NCBI]
|
0.000446586
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000446586
|
|
|
DFNB40
|
[NCBI]
|
0.000446586
|
|
|
AGMX2
|
[NCBI]
|
0.000446586
|
|
|
RP25
|
[NCBI]
|
0.000446586
|
|
|
PEE3
|
[NCBI]
|
0.000446586
|
|
|
DFNB26
|
[NCBI]
|
0.000446586
|
|
|
SPG28
|
[NCBI]
|
0.000446586
|
|
|
EIG2
|
[NCBI]
|
0.000446586
|
|
|
exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like
|
[NCBI]
|
0.000446586
|
|
|
GLC1J
|
[NCBI]
|
0.000446586
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.000446586
|
|
|
ciliary dyskinesia, primary, 5
|
[NCBI]
|
0.000446586
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.000446586
|
|
|
HSCR8
|
[NCBI]
|
0.000446586
|
|
|
BMND7
|
[NCBI]
|
0.000446586
|
|
|
DFNB39
|
[NCBI]
|
0.000446586
|
|
|
CTPP5
|
[NCBI]
|
0.000446586
|
|
|
DFNA16
|
[NCBI]
|
0.000446586
|
|
|
hodgkin disease, y-linked pseudoautosomal
|
[NCBI]
|
0.000446586
|
|
|
DFNB62
|
[NCBI]
|
0.000446586
|
|
|
AIS4
|
[NCBI]
|
0.000446586
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.000446586
|
|
|
hypertensive nephropathy
|
[NCBI]
|
0.000446586
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.000446586
|
|
|
SCA23
|
[NCBI]
|
0.000446586
|
|
|
LKE
|
[NCBI]
|
0.000446586
|
|
|
restless legs syndrome, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
SQTL1
|
[NCBI]
|
0.000446586
|
|
|
van der woude syndrome 2
|
[NCBI]
|
0.000446586
|
|
|
DFNA30
|
[NCBI]
|
0.000446586
|
|
|
DFNB55
|
[NCBI]
|
0.000446586
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.000446586
|
|
|
MRX72
|
[NCBI]
|
0.000446586
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000446586
|
|
|
gallbladder disease 2
|
[NCBI]
|
0.000446586
|
|
|
amyotrophic lateral sclerosis 7
|
[NCBI]
|
0.000446586
|
|
|
cataract, nuclear progressive
|
[NCBI]
|
0.000446586
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.000446586
|
|
|
abidi x-linked mental retardation syndrome
|
[NCBI]
|
0.000446586
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000446586
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.000446586
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000446586
|
|
|
DFNB63
|
[NCBI]
|
0.000446586
|
|
|
noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2
|
[NCBI]
|
0.000446586
|
|
|
SCKL2
|
[NCBI]
|
0.000446586
|
|
|
RP28
|
[NCBI]
|
0.000446586
|
|
|
hypertension, essential, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
MRX52
|
[NCBI]
|
0.000446586
|
|
|
lung cancer 1
|
[NCBI]
|
0.000446586
|
|
|
myopia 11
|
[NCBI]
|
0.000446586
|
|
|
BMND6
|
[NCBI]
|
0.000446586
|
|
|
SLEN1
|
[NCBI]
|
0.000446586
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000446586
|
|
|
AMCX5
|
[NCBI]
|
0.000446586
|
|
|
GLC1B
|
[NCBI]
|
0.000446586
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
GLC1D
|
[NCBI]
|
0.000446586
|
|
|
SCA18
|
[NCBI]
|
0.000446586
|
|
|
PORC
|
[NCBI]
|
0.000446586
|
|
|
ciliary dyskinesia, primary, 4
|
[NCBI]
|
0.000446586
|
|
|
DFNA47
|
[NCBI]
|
0.000446586
|
|
|
schizophrenia 12
|
[NCBI]
|
0.000446586
|
|
|
PFM3
|
[NCBI]
|
0.000446586
|
|
|
SCA28
|
[NCBI]
|
0.000446586
|
|
|
DFNA43
|
[NCBI]
|
0.000446586
|
|
|
LAH3
|
[NCBI]
|
0.000446586
|
|
|
intelligence quantitative trait locus 3
|
[NCBI]
|
0.000446586
|
|
|
DFNM1
|
[NCBI]
|
0.000446586
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2
|
[NCBI]
|
0.000446586
|
|
|
prostate cancer, hereditary, 5
|
[NCBI]
|
0.000446586
|
|
|
OTSC4
|
[NCBI]
|
0.000446586
|
|
|
autoimmune thyroid disease, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
EMWX
|
[NCBI]
|
0.000446586
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000446586
|
|
|
OTSC2
|
[NCBI]
|
0.000446586
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 3
|
[NCBI]
|
0.000446586
|
|
|
GLC1H
|
[NCBI]
|
0.000446586
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000446586
|
|
|
muscular dystrophy, congenital, 1b
|
[NCBI]
|
0.000446586
|
|
|
CATCN1
|
[NCBI]
|
0.000446586
|
|
|
alopecia-mental retardation syndrome 2
|
[NCBI]
|
0.000446586
|
|
|
MENAQ1
|
[NCBI]
|
0.000446586
|
|
|
DFNA24
|
[NCBI]
|
0.000446586
|
|
|
ATFB2
|
[NCBI]
|
0.000446586
|
|
|
OTSC5
|
[NCBI]
|
0.000446586
|
|
|
PNKD2
|
[NCBI]
|
0.000446586
|
|
|
OTSC3
|
[NCBI]
|
0.000446586
|
|
|
SLEN3
|
[NCBI]
|
0.000446586
|
|
|
GINGF3
|
[NCBI]
|
0.000446586
|
|
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000446586
|
|
|
hematocrit/hemoglobin quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000446586
|
|
|
narcolepsy 2
|
[NCBI]
|
0.000446586
|
|
|
SLEN2
|
[NCBI]
|
0.000446586
|
|
|
FEB6
|
[NCBI]
|
0.000446586
|
|
|
MYMY2
|
[NCBI]
|
0.000446586
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000446586
|
|
|
SCAR7
|
[NCBI]
|
0.000446586
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000446586
|
|
|
FGS4
|
[NCBI]
|
0.000446586
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.000446586
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.000446586
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
prostate cancer, hereditary, 4
|
[NCBI]
|
0.000446586
|
|
|
HDLCQ1
|
[NCBI]
|
0.000446586
|
|
|
DFNB68
|
[NCBI]
|
0.000446586
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.000446586
|
|
|
DFNA53
|
[NCBI]
|
0.000446586
|
|
|
SPG29
|
[NCBI]
|
0.000446586
|
|
|
mental retardation, truncal obesity, retinal dystrophy, and micropenis
|
[NCBI]
|
0.000446586
|
|
|
narcolepsy 3
|
[NCBI]
|
0.000446586
|
|
|
longevity 1
|
[NCBI]
|
0.000446586
|
|
|
SCZD9
|
[NCBI]
|
0.000438447
|
|
|
IDDM4
|
[NCBI]
|
0.000427396
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.000425128
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000425128
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.000425128
|
|
|
ANON1
|
[NCBI]
|
0.000425128
|
|
|
MCOPS1
|
[NCBI]
|
0.000425128
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000401892
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000401892
|
|
|
DYX3
|
[NCBI]
|
0.000401892
|
|
|
MPD2
|
[NCBI]
|
0.000401892
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000401892
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.000401892
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000401892
|
|
|
sclerotylosis
|
[NCBI]
|
0.000401892
|
|
|
HHC3
|
[NCBI]
|
0.000401892
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.000401892
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000401892
|
|
|
CTAA2
|
[NCBI]
|
0.000401892
|
|
|
EVR3
|
[NCBI]
|
0.000401892
|
|
|
OB10P
|
[NCBI]
|
0.000401892
|
|
|
amyotrophy, neurogenic scapuloperoneal, new england type
|
[NCBI]
|
0.000401892
|
|
|
BRCA3
|
[NCBI]
|
0.000401892
|
|
|
HPC1
|
[NCBI]
|
0.00039571
|
|
|
SCZD7
|
[NCBI]
|
0.000361137
|
|
|
IGES
|
[NCBI]
|
0.000361137
|
|
|
MG
|
[NCBI]
|
0.000348046
|
|
|
IGER
|
[NCBI]
|
0.000340735
|
|
|
SPG3A
|
[NCBI]
|
0.000328337
|
|
|
IBD1
|
[NCBI]
|
0.000322456
|
|
|
SPG6
|
[NCBI]
|
0.000320771
|
|
|
SCZD
|
[NCBI]
|
0.00031937
|
|
|
MDD
|
[NCBI]
|
0.000319273
|
|
|
prostate cancer
|
[NCBI]
|
0.000310137
|
|
|
CELIAC2
|
[NCBI]
|
0.000308008
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000308008
|
|
|
OPA4
|
[NCBI]
|
0.000308008
|
|
|
ETM2
|
[NCBI]
|
0.000308008
|
|
|
AUTS5
|
[NCBI]
|
0.000308008
|
|
|
AD14
|
[NCBI]
|
0.000308008
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000308008
|
|
|
CMD1B
|
[NCBI]
|
0.000308008
|
|
|
CORD7
|
[NCBI]
|
0.000308008
|
|
|
IBD3
|
[NCBI]
|
0.000308008
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.000308008
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.000308008
|
|
|
OFC3
|
[NCBI]
|
0.000308008
|
|
|
AD13
|
[NCBI]
|
0.000308008
|
|
|
BULN1
|
[NCBI]
|
0.000307884
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.000299124
|
|
|
CMT2A1
|
[NCBI]
|
0.000293662
|
|
|
VWS
|
[NCBI]
|
0.000283893
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000283076
|
|
|
SPG4
|
[NCBI]
|
0.000266391
|
|
|
OTSC1
|
[NCBI]
|
0.000262894
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000262894
|
|
|
PSORS1
|
[NCBI]
|
0.000259684
|
|
|
FHM1
|
[NCBI]
|
0.000247567
|
|
|
EA2
|
[NCBI]
|
0.000245893
|
|
|
FHM2
|
[NCBI]
|
0.000245893
|
|
|
CMT2A2
|
[NCBI]
|
0.000242708
|
|
|
EKD2
|
[NCBI]
|
0.000240612
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000240612
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.000240612
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000240612
|
|
|
CNC2
|
[NCBI]
|
0.000240612
|
|
|
SLEB2
|
[NCBI]
|
0.00023524
|
|
|
CMT2B
|
[NCBI]
|
0.000231667
|
|
|
ETM1
|
[NCBI]
|
0.000224935
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000207772
|
|
|
CMM2
|
[NCBI]
|
0.000207464
|
|
|
obesity
|
[NCBI]
|
0.000207174
|
|
|
SCZD4
|
[NCBI]
|
0.00020488
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
0.000204198
|
|
|
MCKD2
|
[NCBI]
|
0.000204198
|
|
|
AITD3
|
[NCBI]
|
0.000204198
|
|
|
neuropathy, hereditary sensory and autonomic, type i, with cough and gastroesophageal reflux
|
[NCBI]
|
0.000200852
|
|
|
EA3
|
[NCBI]
|
0.000200852
|
|
|
CMD1H
|
[NCBI]
|
0.000200852
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.000200852
|
|
|
DFNB33
|
[NCBI]
|
0.000200852
|
|
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.000200852
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.000200852
|
|
|
lentiginosis, inherited patterned
|
[NCBI]
|
0.000200852
|
|
|
HCFP2
|
[NCBI]
|
0.000200852
|
|
|
CMD1K
|
[NCBI]
|
0.000200852
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000200852
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.000200852
|
|
|
SCA25
|
[NCBI]
|
0.000200852
|
|
|
WS2B
|
[NCBI]
|
0.000200852
|
|
|
STUT2
|
[NCBI]
|
0.000200852
|
|
|
glucocorticoid deficiency 3
|
[NCBI]
|
0.000200852
|
|
|
CMT2G
|
[NCBI]
|
0.000200852
|
|
|
DYT13
|
[NCBI]
|
0.000200852
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.000200852
|
|
|
AIS3
|
[NCBI]
|
0.000200852
|
|
|
SPAX1
|
[NCBI]
|
0.000200852
|
|
|
LGMD1F
|
[NCBI]
|
0.000200852
|
|
|
SPG14
|
[NCBI]
|
0.000200852
|
|
|
DFNA18
|
[NCBI]
|
0.000200852
|
|
|
cone-rod dystrophy and amelogenesis imperfecta
|
[NCBI]
|
0.000200852
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.000200852
|
|
|
LGMD2L
|
[NCBI]
|
0.000200852
|
|
|
ATOD5
|
[NCBI]
|
0.000200852
|
|
|
BMND5
|
[NCBI]
|
0.000200852
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.000200852
|
|
|
MCOPCB2
|
[NCBI]
|
0.000200852
|
|
|
prostate cancer, hereditary, 9
|
[NCBI]
|
0.000200852
|
|
|
CELIAC5
|
[NCBI]
|
0.000200852
|
|
|
MAFD4
|
[NCBI]
|
0.000200852
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.000200852
|
|
|
NEM6
|
[NCBI]
|
0.000200852
|
|
|
VMD1
|
[NCBI]
|
0.000200852
|
|
|
HDL3
|
[NCBI]
|
0.000200852
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.000200852
|
|
|
MRT12
|
[NCBI]
|
0.000200852
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.000200852
|
|
|
PTLAH
|
[NCBI]
|
0.000200852
|
|
|
DFNA7
|
[NCBI]
|
0.000200852
|
|
|
NNCI
|
[NCBI]
|
0.000200852
|
|
|
prostate cancer, hereditary, 6
|
[NCBI]
|
0.000200852
|
|
|
SCA21
|
[NCBI]
|
0.000200852
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000200852
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000200852
|
|
|
MPD3
|
[NCBI]
|
0.000200852
|
|
|
cdags syndrome
|
[NCBI]
|
0.000200852
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000200852
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000200852
|
|
|
IBD4
|
[NCBI]
|
0.000200852
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000200852
|
|
|
hypertension, essential, susceptibility to, 2
|
[NCBI]
|
0.000200852
|
|
|
ENUR2
|
[NCBI]
|
0.000200852
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000200852
|
|
|
AIS2
|
[NCBI]
|
0.000200852
|
|
|
RCM2
|
[NCBI]
|
0.000200852
|
|
|
IDDM6
|
[NCBI]
|
0.000200852
|
|
|
NYS4
|
[NCBI]
|
0.000200852
|
|
|
epilepsy, myoclonic, benign adult familial, type 2
|
[NCBI]
|
0.000200852
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.000200852
|
|
|
DYX8
|
[NCBI]
|
0.000200852
|
|
|
MACOM
|
[NCBI]
|
0.000200852
|
|
|
myopia 4
|
[NCBI]
|
0.000200852
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000200852
|
|
|
ENUR1
|
[NCBI]
|
0.000200852
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.000200852
|
|
|
leber congenital amaurosis, type ix
|
[NCBI]
|
0.000200852
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000200852
|
|
|
AUTS8
|
[NCBI]
|
0.000200852
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 2
|
[NCBI]
|
0.000200852
|
|
|
MRXS7
|
[NCBI]
|
0.000200852
|
|
|
parkinsonism, early-onset, with mental retardation
|
[NCBI]
|
0.000200852
|
|
|
retinal cone dystrophy 2
|
[NCBI]
|
0.000200852
|
|
|
GLC1A
|
[NCBI]
|
0.000197868
|
|
|
HNFJ
|
[NCBI]
|
0.000197265
|
|
|
EGF
|
[NCBI]
|
0.000194421
|
|
|
MODY
|
[NCBI]
|
0.00019346
|
|
|
VEGF
|
[NCBI]
|
0.000191642
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000189524
|
|
|
BMND3
|
[NCBI]
|
0.000189524
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000189524
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.000189524
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000189524
|
|
|
CFEOM3
|
[NCBI]
|
0.000189524
|
|
|
mental health wellness 1
|
[NCBI]
|
0.000189524
|
|
|
MEAX
|
[NCBI]
|
0.000189524
|
|
|
PSORS4
|
[NCBI]
|
0.000189524
|
|
|
MNG1
|
[NCBI]
|
0.000189524
|
|
|
graves disease
|
[NCBI]
|
0.000179508
|
|
|
NPHP1
|
[NCBI]
|
0.000178391
|
|
|
NIDDM
|
[NCBI]
|
0.000174036
|
|
|
RP11
|
[NCBI]
|
0.000172048
|
|
|
SCZD2
|
[NCBI]
|
0.000172048
|
|
|
CCZS
|
[NCBI]
|
0.000168629
|
|
|
CTPP3
|
[NCBI]
|
0.000168629
|
|
|
SCZD8
|
[NCBI]
|
0.000168629
|
|
|
MRX54
|
[NCBI]
|
0.000168629
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.000168629
|
|
|
BRCA1
|
[NCBI]
|
0.000167836
|
|
|
DFNA6
|
[NCBI]
|
0.000163879
|
|
|
MYP2
|
[NCBI]
|
0.000162733
|
|
|
CMT1A
|
[NCBI]
|
0.000162551
|
|
|
FA
|
[NCBI]
|
0.000159522
|
|
|
hypertension, essential
|
[NCBI]
|
0.000158261
|
|
|
TNF
|
[NCBI]
|
0.000157144
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
0.000156813
|
|
|
CCA3
|
[NCBI]
|
0.000156813
|
|
|
RP2
|
[NCBI]
|
0.000155527
|
|
|
DFNB10
|
[NCBI]
|
0.000153129
|
|
|
DFNB8
|
[NCBI]
|
0.000153129
|
|
|
SPG13
|
[NCBI]
|
0.000153129
|
|
|
SCA2
|
[NCBI]
|
0.000150142
|
|
|
JME
|
[NCBI]
|
0.000149908
|
|
|
DFN2
|
[NCBI]
|
0.000149536
|
|
|
IDDM7
|
[NCBI]
|
0.000149536
|
|
|
LGMD2B
|
[NCBI]
|
0.000143841
|
|
|
DFNB1
|
[NCBI]
|
0.000141804
|
|
|
SCA5
|
[NCBI]
|
0.000141081
|
|
|
CZP3
|
[NCBI]
|
0.000141081
|
|
|
DURS1
|
[NCBI]
|
0.000137826
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.000137826
|
|
|
PAND1
|
[NCBI]
|
0.000137826
|
|
|
EKD1
|
[NCBI]
|
0.000135548
|
|
|
DHRD
|
[NCBI]
|
0.0001331
|
|
|
acromegaly
|
[NCBI]
|
0.0001331
|
|
|
SCZD1
|
[NCBI]
|
0.0001331
|
|
|
DYX2
|
[NCBI]
|
0.0001331
|
|
|
RP3
|
[NCBI]
|
0.000131407
|
|
|
MEN2A
|
[NCBI]
|
0.000131341
|
|
|
RP10
|
[NCBI]
|
0.000131224
|
|
|
SCA6
|
[NCBI]
|
0.000129864
|
|
|
LGMD2C
|
[NCBI]
|
0.000128222
|
|
|
HNA
|
[NCBI]
|
0.000123823
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.00012357
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
0.00012289
|
|
|
SPG11
|
[NCBI]
|
0.00012289
|
|
|
SPG10
|
[NCBI]
|
0.00012289
|
|
|
HMN2A
|
[NCBI]
|
0.00012289
|
|
|
NPHP3
|
[NCBI]
|
0.00012289
|
|
|
CMT2D
|
[NCBI]
|
0.00012289
|
|
|
PKD2
|
[NCBI]
|
0.00012265
|
|
|
IDDM17
|
[NCBI]
|
0.000120233
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000120233
|
|
|
pyle disease
|
[NCBI]
|
0.000120233
|
|
|
MRX2
|
[NCBI]
|
0.000120233
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.000120233
|
|
|
MHAC
|
[NCBI]
|
0.000120233
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000120233
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000120233
|
|
|
cerebellar atrophy with progressive microcephaly
|
[NCBI]
|
0.000120233
|
|
|
OPA2
|
[NCBI]
|
0.000120233
|
|
|
ATFB1
|
[NCBI]
|
0.000120233
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
0.000120233
|
|
|
auditory neuropathy, autosomal dominant, 1
|
[NCBI]
|
0.000120233
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000120233
|
|
|
MRX20
|
[NCBI]
|
0.000120233
|
|
|
cowchock syndrome
|
[NCBI]
|
0.000120233
|
|
|
CMTX3
|
[NCBI]
|
0.000120233
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000120233
|
|
|
ALSFTD2
|
[NCBI]
|
0.000120233
|
|
|
CND
|
[NCBI]
|
0.000120233
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000120233
|
|
|
IDDM18
|
[NCBI]
|
0.000120233
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000120233
|
|
|
SCAR6
|
[NCBI]
|
0.000120233
|
|
|
auditory neuropathy, x-linked, 1, with peripheral sensory neuropathy
|
[NCBI]
|
0.000120233
|
|
|
LI5
|
[NCBI]
|
0.000120233
|
|
|
HHC2
|
[NCBI]
|
0.000120233
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000120233
|
|
|
PDR
|
[NCBI]
|
0.000120233
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000120233
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000120233
|
|
|
DYT15
|
[NCBI]
|
0.000120233
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000120233
|
|
|
AUTS10
|
[NCBI]
|
0.000120233
|
|
|
SPG19
|
[NCBI]
|
0.000120233
|
|
|
CVD1
|
[NCBI]
|
0.000120233
|
|
|
ORW3
|
[NCBI]
|
0.000120233
|
|
|
GLC1M
|
[NCBI]
|
0.000120233
|
|
|
preauricular fistulae, congenital
|
[NCBI]
|
0.000120233
|
|
|
PEE1
|
[NCBI]
|
0.000119973
|
|
|
HEPOD
|
[NCBI]
|
0.000119626
|
|
|
PEE4
|
[NCBI]
|
0.00011896
|
|
|
ARMD10
|
[NCBI]
|
0.00011896
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
0.00011896
|
|
|
CMD3A
|
[NCBI]
|
0.00011896
|
|
|
HMERF
|
[NCBI]
|
0.00011896
|
|
|
BOS3
|
[NCBI]
|
0.00011896
|
|
|
DDU
|
[NCBI]
|
0.00011896
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.000117608
|
|
|
SCZD6
|
[NCBI]
|
0.000117608
|
|
|
BFSP2
|
[NCBI]
|
0.000116648
|
|
|
MFN2
|
[NCBI]
|
0.000116465
|
|
|
PKD3
|
[NCBI]
|
0.00011568
|
|
|
SPG17
|
[NCBI]
|
0.00011568
|
|
|
NHS
|
[NCBI]
|
0.000115679
|
|
|
HSAN1
|
[NCBI]
|
0.000115679
|
|
|
PWS
|
[NCBI]
|
0.000112123
|
|
|
DFNA12
|
[NCBI]
|
0.000109335
|
|
|
ARX
|
[NCBI]
|
0.000109233
|
|
|
HYPP
|
[NCBI]
|
0.000108998
|
|
|
USH2A
|
[NCBI]
|
0.000108439
|
|
|
ARMD1
|
[NCBI]
|
0.00010688
|
|
|
POAG
|
[NCBI]
|
0.000104305
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.000104305
|
|
|
LAH
|
[NCBI]
|
0.000102073
|
|
|
CFEOM2
|
[NCBI]
|
0.000102073
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
0.000102073
|
|
|
SCA15
|
[NCBI]
|
0.000102073
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
0.000102073
|
|
|
CELIAC4
|
[NCBI]
|
0.000102073
|
|
|
CMD1C
|
[NCBI]
|
0.000102073
|
|
|
AIS1
|
[NCBI]
|
0.000102073
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
0.000102073
|
|
|
DPR
|
[NCBI]
|
0.000102073
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
0.000102073
|
|
|
SCA13
|
[NCBI]
|
0.000102073
|
|
|
EBN2
|
[NCBI]
|
0.000102073
|
|
|
CMT1C
|
[NCBI]
|
0.000102073
|
|
|
PDB
|
[NCBI]
|
0.000101935
|
|
|
CPX
|
[NCBI]
|
0.000101935
|
|
|
central core disease of muscle
|
[NCBI]
|
0.000101935
|
|
|
GDI1
|
[NCBI]
|
0.000100152
|
|
|
osteoarthritis
|
[NCBI]
|
9.89193e-05
|
|
|
ARH
|
[NCBI]
|
9.85792e-05
|
|
|
EIG
|
[NCBI]
|
9.53017e-05
|
|
|
CORDX1
|
[NCBI]
|
9.39449e-05
|
|
|
USH1C
|
[NCBI]
|
9.39449e-05
|
|
|
CFEOM1
|
[NCBI]
|
9.39449e-05
|
|
|
BHD
|
[NCBI]
|
9.39449e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
9.39449e-05
|
|
|
SPDA1
|
[NCBI]
|
9.32979e-05
|
|
|
DAR
|
[NCBI]
|
9.32979e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
9.30063e-05
|
|
|
PRL
|
[NCBI]
|
9.20909e-05
|
|
|
AMCN
|
[NCBI]
|
9.18068e-05
|
|
|
dermatitis, atopic
|
[NCBI]
|
9.18068e-05
|
|
|
CRYAA
|
[NCBI]
|
9.10123e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
9.06711e-05
|
|
|
RP7
|
[NCBI]
|
9.06065e-05
|
|
|
NPHP4
|
[NCBI]
|
9.06065e-05
|
|
|
AH
|
[NCBI]
|
9.06065e-05
|
|
|
HCHOLA3
|
[NCBI]
|
9.06065e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
9.06065e-05
|
|
|
DFNB12
|
[NCBI]
|
9.06065e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
9.06065e-05
|
|
|
GDD
|
[NCBI]
|
9.06065e-05
|
|
|
DFNB6
|
[NCBI]
|
9.06065e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
9.06065e-05
|
|
|
CMT1B
|
[NCBI]
|
8.99619e-05
|
|
|
NGFB
|
[NCBI]
|
8.98746e-05
|
|
|
BHC
|
[NCBI]
|
8.97021e-05
|
|
|
ADLTE
|
[NCBI]
|
8.97021e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
8.97021e-05
|
|
|
JH
|
[NCBI]
|
8.97021e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
8.88824e-05
|
|
|
APC
|
[NCBI]
|
8.87589e-05
|
|
|
PGP
|
[NCBI]
|
8.85159e-05
|
|
|
PCOS1
|
[NCBI]
|
8.75289e-05
|
|
|
CMDD
|
[NCBI]
|
8.57942e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
8.57942e-05
|
|
|
SCA1
|
[NCBI]
|
8.38309e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
8.2176e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
8.2176e-05
|
|
|
SPCH1
|
[NCBI]
|
8.2176e-05
|
|
|
AHDS
|
[NCBI]
|
8.2176e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
8.2176e-05
|
|
|
SPG2
|
[NCBI]
|
8.2176e-05
|
|
|
RP13
|
[NCBI]
|
8.19142e-05
|
|
|
DFNA20
|
[NCBI]
|
8.19142e-05
|
|
|
CMD1E
|
[NCBI]
|
8.19142e-05
|
|
|
HOMG2
|
[NCBI]
|
8.19142e-05
|
|
|
cherubism
|
[NCBI]
|
8.19142e-05
|
|
|
PARK2
|
[NCBI]
|
8.1196e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
7.88108e-05
|
|
|
EAOH
|
[NCBI]
|
7.88108e-05
|
|
|
SPG3A
|
[NCBI]
|
7.87178e-05
|
|
|
CISS1
|
[NCBI]
|
7.83995e-05
|
|
|
platyspondyly with amelogenesis imperfecta
|
[NCBI]
|
7.83995e-05
|
|
|
HHF5
|
[NCBI]
|
7.83995e-05
|
|
|
NEM5
|
[NCBI]
|
7.83995e-05
|
|
|
TSC3
|
[NCBI]
|
7.83995e-05
|
|
|
CATCN2
|
[NCBI]
|
7.83995e-05
|
|
|
DFNB23
|
[NCBI]
|
7.83995e-05
|
|
|
oligodontia-colorectal cancer syndrome
|
[NCBI]
|
7.83995e-05
|
|
|
MRX14
|
[NCBI]
|
7.83995e-05
|
|
|
ATFB3
|
[NCBI]
|
7.83995e-05
|
|
|
CMH2
|
[NCBI]
|
7.83995e-05
|
|
|
epilepsy, benign neonatal, autosomal recessive
|
[NCBI]
|
7.83995e-05
|
|
|
ROCA
|
[NCBI]
|
7.83995e-05
|
|
|
hearing loss, sensorineural, with enamel hypoplasia and nail defects
|
[NCBI]
|
7.83995e-05
|
|
|
microcephaly with simplified gyral pattern
|
[NCBI]
|
7.83995e-05
|
|
|
BFLS
|
[NCBI]
|
7.56687e-05
|
|
|
EBN1
|
[NCBI]
|
7.56687e-05
|
|
|
GEFS+
|
[NCBI]
|
7.56687e-05
|
|
|
CRYBA1
|
[NCBI]
|
7.55673e-05
|
|
|
ALD
|
[NCBI]
|
7.51356e-05
|
|
|
CLN3
|
[NCBI]
|
7.49944e-05
|
|
|
CMTX1
|
[NCBI]
|
7.49944e-05
|
|
|
RP9
|
[NCBI]
|
7.49292e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
7.49292e-05
|
|
|
STHAG3
|
[NCBI]
|
7.49292e-05
|
|
|
EJM1
|
[NCBI]
|
7.49292e-05
|
|
|
body mass index
|
[NCBI]
|
7.49292e-05
|
|
|
DSAP1
|
[NCBI]
|
7.49292e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
7.49292e-05
|
|
|
CCA2
|
[NCBI]
|
7.49292e-05
|
|
|
naegeli syndrome
|
[NCBI]
|
7.49292e-05
|
|
|
IDDM5
|
[NCBI]
|
7.49292e-05
|
|
|
ARMD7
|
[NCBI]
|
7.49292e-05
|
|
|
HMPS1
|
[NCBI]
|
7.47133e-05
|
|
|
keratolytic winter erythema
|
[NCBI]
|
7.47133e-05
|
|
|
EXT3
|
[NCBI]
|
7.47133e-05
|
|
|
spinal muscular atrophy, distal, congenital nonprogressive
|
[NCBI]
|
7.47133e-05
|
|
|
CCV
|
[NCBI]
|
7.47133e-05
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
7.47133e-05
|
|
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
7.47133e-05
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
7.47133e-05
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
7.47133e-05
|
|
|
gout susceptibility 1
|
[NCBI]
|
7.47133e-05
|
|
|
CMT2B2
|
[NCBI]
|
7.47133e-05
|
|
|
PSNP2
|
[NCBI]
|
7.47133e-05
|
|
|
pulmonary function
|
[NCBI]
|
7.47133e-05
|
|
|
CORD8
|
[NCBI]
|
7.47133e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
7.47133e-05
|
|
|
eosinophilia, familial
|
[NCBI]
|
7.47133e-05
|
|
|
DFNB15
|
[NCBI]
|
7.47133e-05
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
7.47133e-05
|
|
|
EA4
|
[NCBI]
|
7.47133e-05
|
|
|
DYX5
|
[NCBI]
|
7.47133e-05
|
|
|
ALS5
|
[NCBI]
|
7.47133e-05
|
|
|
ALSFTD1
|
[NCBI]
|
7.47133e-05
|
|
|
dupuytren contracture
|
[NCBI]
|
7.47133e-05
|
|
|
GSM1
|
[NCBI]
|
7.47133e-05
|
|
|
SCA19
|
[NCBI]
|
7.47133e-05
|
|
|
ARVD5
|
[NCBI]
|
7.47133e-05
|
|
|
DYX6
|
[NCBI]
|
7.47133e-05
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
7.47133e-05
|
|
|
PTOS1
|
[NCBI]
|
7.47133e-05
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
7.47133e-05
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
7.47133e-05
|
|
|
speech-sound disorder
|
[NCBI]
|
7.47133e-05
|
|
|
HBFQTL4
|
[NCBI]
|
7.47133e-05
|
|
|
muscular dystrophy, congenital, merosin-positive
|
[NCBI]
|
7.47133e-05
|
|
|
CORD5
|
[NCBI]
|
7.47133e-05
|
|
|
MYP1
|
[NCBI]
|
7.47133e-05
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
7.47133e-05
|
|
|
SCZD5
|
[NCBI]
|
7.47133e-05
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
7.47133e-05
|
|
|
ARVD4
|
[NCBI]
|
7.47133e-05
|
|
|
CHDM
|
[NCBI]
|
7.47133e-05
|
|
|
NIPA1
|
[NCBI]
|
7.42934e-05
|
|
|
LW
|
[NCBI]
|
7.42934e-05
|
|
|
GJA3
|
[NCBI]
|
7.41407e-05
|
|
|
LQT1
|
[NCBI]
|
7.36709e-05
|
|
|
GUCY2D
|
[NCBI]
|
7.27977e-05
|
|
|
ORW2
|
[NCBI]
|
7.27247e-05
|
|
|
PMC
|
[NCBI]
|
7.27247e-05
|
|
|
WDM
|
[NCBI]
|
7.08217e-05
|
|
|
IBD5
|
[NCBI]
|
7.08217e-05
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
7.08217e-05
|
|
|
NPHP2
|
[NCBI]
|
6.91065e-05
|
|
|
opitz syndrome
|
[NCBI]
|
6.91065e-05
|
|
|
KCS
|
[NCBI]
|
6.91065e-05
|
|
|
vitiligo
|
[NCBI]
|
6.91065e-05
|
|
|
HRD
|
[NCBI]
|
6.91065e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
6.91065e-05
|
|
|
AMDM
|
[NCBI]
|
6.91065e-05
|
|
|
WFS1
|
[NCBI]
|
6.80989e-05
|
|
|
BTK
|
[NCBI]
|
6.80249e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
6.76176e-05
|
|
|
TM4SF2
|
[NCBI]
|
6.75956e-05
|
|
|
KIF1B
|
[NCBI]
|
6.75956e-05
|
|
|
CNC1
|
[NCBI]
|
6.73498e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
6.73498e-05
|
|
|
CDH23
|
[NCBI]
|
6.70614e-05
|
|
|
DISC2
|
[NCBI]
|
6.59715e-05
|
|
|
OFC1
|
[NCBI]
|
6.54696e-05
|
|
|
KLK3
|
[NCBI]
|
6.52192e-05
|
|
|
CSNB1A
|
[NCBI]
|
6.4886e-05
|
|
|
TGD
|
[NCBI]
|
6.4886e-05
|
|
|
autism
|
[NCBI]
|
6.44579e-05
|
|
|
IDDM
|
[NCBI]
|
6.43334e-05
|
|
|
CRYAB
|
[NCBI]
|
6.42069e-05
|
|
|
NIDDM1
|
[NCBI]
|
6.41276e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
6.41276e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
6.41276e-05
|
|
|
RP12
|
[NCBI]
|
6.41276e-05
|
|
|
ADHR
|
[NCBI]
|
6.41276e-05
|
|
|
SCA12
|
[NCBI]
|
6.41276e-05
|
|
|
NPY
|
[NCBI]
|
6.29958e-05
|
|
|
JPS
|
[NCBI]
|
6.28016e-05
|
|
|
LMBR1
|
[NCBI]
|
6.27866e-05
|
|
|
ANKH
|
[NCBI]
|
6.27866e-05
|
|
|
ACHE
|
[NCBI]
|
6.14985e-05
|
|
|
MDM1
|
[NCBI]
|
6.08058e-05
|
|
|
MHA
|
[NCBI]
|
6.03393e-05
|
|
|
thiourea tasting
|
[NCBI]
|
6.03393e-05
|
|
|
PNKD1
|
[NCBI]
|
6.03393e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
5.97899e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
5.97899e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
5.97899e-05
|
|
|
DFNB9
|
[NCBI]
|
5.97899e-05
|
|
|
MCPH5
|
[NCBI]
|
5.97899e-05
|
|
|
USH1D
|
[NCBI]
|
5.97899e-05
|
|
|
DA1
|
[NCBI]
|
5.97899e-05
|
|
|
DFNA2
|
[NCBI]
|
5.97899e-05
|
|
|
PITX3
|
[NCBI]
|
5.90291e-05
|
|
|
loc387715 gene
|
[NCBI]
|
5.90291e-05
|
|
|
DYX1
|
[NCBI]
|
5.82351e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
5.82351e-05
|
|
|
SMA2
|
[NCBI]
|
5.82351e-05
|
|
|
chiari malformation type i
|
[NCBI]
|
5.76526e-05
|
|
|
MCDR1
|
[NCBI]
|
5.76526e-05
|
|
|
JBTS1
|
[NCBI]
|
5.76526e-05
|
|
|
CRYGC
|
[NCBI]
|
5.74185e-05
|
|
|
SEPT9
|
[NCBI]
|
5.74185e-05
|
|
|
AD
|
[NCBI]
|
5.69929e-05
|
|
|
MYO7A
|
[NCBI]
|
5.66837e-05
|
|
|
MODY3
|
[NCBI]
|
5.59563e-05
|
|
|
HNPCC2
|
[NCBI]
|
5.59563e-05
|
|
|
DGI1
|
[NCBI]
|
5.59563e-05
|
|
|
SLSN1
|
[NCBI]
|
5.59563e-05
|
|
|
BDA1
|
[NCBI]
|
5.59563e-05
|
|
|
SCAR1
|
[NCBI]
|
5.59563e-05
|
|
|
GVM
|
[NCBI]
|
5.59563e-05
|
|
|
GINGF
|
[NCBI]
|
5.59563e-05
|
|
|
OCD1
|
[NCBI]
|
5.59563e-05
|
|
|
RYR1
|
[NCBI]
|
5.58058e-05
|
|
|
OPTN
|
[NCBI]
|
5.54423e-05
|
|
|
glutathione s-transferase, omega-1
|
[NCBI]
|
5.46341e-05
|
|
|
PCSK9
|
[NCBI]
|
5.45892e-05
|
|
|
LU
|
[NCBI]
|
5.45892e-05
|
|
|
CRYGD
|
[NCBI]
|
5.45892e-05
|
|
|
BRCA2
|
[NCBI]
|
5.44577e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
5.44244e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
5.43206e-05
|
|
|
HSAS
|
[NCBI]
|
5.43206e-05
|
|
|
VHL
|
[NCBI]
|
5.37637e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
5.33321e-05
|
|
|
RHO
|
[NCBI]
|
5.3033e-05
|
|
|
MHS1
|
[NCBI]
|
5.29856e-05
|
|
|
MRXS13
|
[NCBI]
|
5.25295e-05
|
|
|
CMT4A
|
[NCBI]
|
5.25295e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
5.25295e-05
|
|
|
CLN5
|
[NCBI]
|
5.25295e-05
|
|
|
CYLD
|
[NCBI]
|
5.25295e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
5.25295e-05
|
|
|
SACS
|
[NCBI]
|
5.25295e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
5.25295e-05
|
|
|
HRPT2
|
[NCBI]
|
5.25295e-05
|
|
|
acheiropody
|
[NCBI]
|
5.25295e-05
|
|
|
RP1
|
[NCBI]
|
5.24957e-05
|
|
|
PRNP
|
[NCBI]
|
5.22424e-05
|
|
|
CRYBB2
|
[NCBI]
|
5.2161e-05
|
|
|
SCA7
|
[NCBI]
|
5.17358e-05
|
|
|
EPO
|
[NCBI]
|
5.14366e-05
|
|
|
WFS2
|
[NCBI]
|
5.10297e-05
|
|
|
LOCS
|
[NCBI]
|
5.10297e-05
|
|
|
NFTC
|
[NCBI]
|
5.10297e-05
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
5.10297e-05
|
|
|
CDD
|
[NCBI]
|
5.10297e-05
|
|
|
MKS4
|
[NCBI]
|
5.10297e-05
|
|
|
SLSN4
|
[NCBI]
|
5.10297e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
5.10297e-05
|
|
|
mast syndrome
|
[NCBI]
|
5.10297e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
5.10297e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
5.10297e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
5.10297e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
5.10297e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
5.10297e-05
|
|
|
LCCS2
|
[NCBI]
|
5.10297e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
5.10297e-05
|
|
|
optic atrophy 3, autosomal dominant
|
[NCBI]
|
5.10297e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2l
|
[NCBI]
|
5.10297e-05
|
|
|
CMT2K
|
[NCBI]
|
5.10297e-05
|
|
|
carney complex variant
|
[NCBI]
|
5.10297e-05
|
|
|
NFRCD
|
[NCBI]
|
5.10297e-05
|
|
|
microphthalmia, isolated, with cataract 4
|
[NCBI]
|
5.10297e-05
|
|
|
XMRE
|
[NCBI]
|
5.10297e-05
|
|
|
cataract, crystalline aculeiform
|
[NCBI]
|
5.10297e-05
|
|
|
CMH8
|
[NCBI]
|
5.10297e-05
|
|
|
CLSD
|
[NCBI]
|
5.10297e-05
|
|
|
SPG5B
|
[NCBI]
|
5.10297e-05
|
|
|
CMH10
|
[NCBI]
|
5.10297e-05
|
|
|
alzheimer disease without neurofibrillary tangles
|
[NCBI]
|
5.10297e-05
|
|
|
SCA16
|
[NCBI]
|
5.10297e-05
|
|
|
DFNA23
|
[NCBI]
|
5.10297e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
5.10297e-05
|
|
|
MRX45
|
[NCBI]
|
5.10297e-05
|
|
|
MCPHA
|
[NCBI]
|
5.10297e-05
|
|
|
deafness, autosomal dominant nonsyndromic sensorineural, due to mutation in myo1a
|
[NCBI]
|
5.10297e-05
|
|
|
MCPH3
|
[NCBI]
|
5.10297e-05
|
|
|
MRXS10
|
[NCBI]
|
5.10297e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate c
|
[NCBI]
|
5.10297e-05
|
|
|
EXT2
|
[NCBI]
|
5.00354e-05
|
|
|
FRDA
|
[NCBI]
|
4.97364e-05
|
|
|
NEF3
|
[NCBI]
|
4.95228e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
4.94381e-05
|
|
|
monilethrix
|
[NCBI]
|
4.94381e-05
|
|
|
BMND1
|
[NCBI]
|
4.94381e-05
|
|
|
ALS2
|
[NCBI]
|
4.94381e-05
|
|
|
ED2
|
[NCBI]
|
4.94381e-05
|
|
|
OPD1
|
[NCBI]
|
4.94381e-05
|
|
|
KFSD
|
[NCBI]
|
4.94381e-05
|
|
|
CMD3B
|
[NCBI]
|
4.94381e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
4.94381e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
4.94381e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
4.94381e-05
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
4.94381e-05
|
|
|
ACTC1
|
[NCBI]
|
4.90646e-05
|
|
|
PTH
|
[NCBI]
|
4.8483e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
4.81945e-05
|
|
|
MJD
|
[NCBI]
|
4.75491e-05
|
|
|
cystinuria
|
[NCBI]
|
4.74781e-05
|
|
|
FCHL
|
[NCBI]
|
4.74781e-05
|
|
|
EA1
|
[NCBI]
|
4.66279e-05
|
|
|
WGN1
|
[NCBI]
|
4.66279e-05
|
|
|
AGS1
|
[NCBI]
|
4.66279e-05
|
|
|
HMN5
|
[NCBI]
|
4.66279e-05
|
|
|
MYOC
|
[NCBI]
|
4.64029e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
4.63217e-05
|
|
|
RTT
|
[NCBI]
|
4.5999e-05
|
|
|
LGMD2A
|
[NCBI]
|
4.59413e-05
|
|
|
PGL1
|
[NCBI]
|
4.59413e-05
|
|
|
FECD2
|
[NCBI]
|
4.58648e-05
|
|
|
GLC1C
|
[NCBI]
|
4.58648e-05
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
4.58648e-05
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
4.58648e-05
|
|
|
CTAA1
|
[NCBI]
|
4.58648e-05
|
|
|
larsen syndrome, recessive
|
[NCBI]
|
4.58648e-05
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
4.58648e-05
|
|
|
EFMR
|
[NCBI]
|
4.58648e-05
|
|
|
acromegaloid facial appearance syndrome
|
[NCBI]
|
4.58648e-05
|
|
|
CMDR
|
[NCBI]
|
4.58648e-05
|
|
|
CTPP1
|
[NCBI]
|
4.58648e-05
|
|
|
molar i reinclusion
|
[NCBI]
|
4.58648e-05
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
4.58648e-05
|
|
|
HBD
|
[NCBI]
|
4.58648e-05
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
4.58648e-05
|
|
|
USH2B
|
[NCBI]
|
4.58648e-05
|
|
|
CRH
|
[NCBI]
|
4.56989e-05
|
|
|
APP
|
[NCBI]
|
4.55192e-05
|
|
|
MS
|
[NCBI]
|
4.52836e-05
|
|
|
HSR
|
[NCBI]
|
4.49036e-05
|
|
|
MIP
|
[NCBI]
|
4.41821e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.41821e-05
|
|
|
MCPH1
|
[NCBI]
|
4.40569e-05
|
|
|
SOST
|
[NCBI]
|
4.40569e-05
|
|
|
SCN1A
|
[NCBI]
|
4.34904e-05
|
|
|
GJB2
|
[NCBI]
|
4.34557e-05
|
|
|
NPHP3
|
[NCBI]
|
4.33433e-05
|
|
|
PKD1
|
[NCBI]
|
4.30857e-05
|
|
|
FCAS
|
[NCBI]
|
4.30463e-05
|
|
|
SOD1
|
[NCBI]
|
4.28438e-05
|
|
|
AS
|
[NCBI]
|
4.2785e-05
|
|
|
MAFD6
|
[NCBI]
|
4.26448e-05
|
|
|
GJA8
|
[NCBI]
|
4.21878e-05
|
|
|
PFIC1
|
[NCBI]
|
4.16919e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
4.16919e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.16919e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
4.16919e-05
|
|
|
IPEX
|
[NCBI]
|
4.16919e-05
|
|
|
MEB
|
[NCBI]
|
4.16811e-05
|
|
|
NOG
|
[NCBI]
|
4.1573e-05
|
|
|
HSPB8
|
[NCBI]
|
4.11724e-05
|
|
|
CHMP4B
|
[NCBI]
|
4.11724e-05
|
|
|
DISC1
|
[NCBI]
|
4.09802e-05
|
|
|
MCPH6
|
[NCBI]
|
4.09508e-05
|
|
|
spastic ataxia
|
[NCBI]
|
4.09508e-05
|
|
|
IAHSP
|
[NCBI]
|
4.09508e-05
|
|
|
MRT3
|
[NCBI]
|
4.09508e-05
|
|
|
SCA11
|
[NCBI]
|
4.09508e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
4.09508e-05
|
|
|
EDM5
|
[NCBI]
|
4.09508e-05
|
|
|
DFNB31
|
[NCBI]
|
4.09508e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
4.09508e-05
|
|
|
ATOD4
|
[NCBI]
|
4.09508e-05
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
4.09508e-05
|
|
|
axenfeld-rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities
|
[NCBI]
|
4.09508e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
4.09508e-05
|
|
|
AI1G
|
[NCBI]
|
4.09508e-05
|
|
|
CMD1P
|
[NCBI]
|
4.09508e-05
|
|
|
meniere disease
|
[NCBI]
|
4.09508e-05
|
|
|
FHM3
|
[NCBI]
|
4.09508e-05
|
|
|
MRX46
|
[NCBI]
|
4.09508e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
4.09508e-05
|
|
|
LCA4
|
[NCBI]
|
4.09508e-05
|
|
|
cochleosaccular degeneration of the inner ear with progressive cataracts
|
[NCBI]
|
4.09508e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
4.09508e-05
|
|
|
ACFD
|
[NCBI]
|
4.09508e-05
|
|
|
brunner syndrome
|
[NCBI]
|
4.09508e-05
|
|
|
DFNB16
|
[NCBI]
|
4.09508e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
4.09508e-05
|
|
|
MRX58
|
[NCBI]
|
4.09508e-05
|
|
|
FEB3
|
[NCBI]
|
4.09508e-05
|
|
|
COD3
|
[NCBI]
|
4.09508e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
4.09508e-05
|
|
|
MRGH
|
[NCBI]
|
4.09508e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
4.09508e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
4.09508e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
4.09508e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
4.09508e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
4.09508e-05
|
|
|
neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive
|
[NCBI]
|
4.09508e-05
|
|
|
RP26
|
[NCBI]
|
4.09508e-05
|
|
|
RBP4
|
[NCBI]
|
4.04079e-05
|
|
|
CHH
|
[NCBI]
|
3.9938e-05
|
|
|
FTL
|
[NCBI]
|
3.98549e-05
|
|
|
MTRNR1
|
[NCBI]
|
3.98549e-05
|
|
|
IBGC1
|
[NCBI]
|
3.98312e-05
|
|
|
MRD
|
[NCBI]
|
3.98312e-05
|
|
|
FEB1
|
[NCBI]
|
3.98312e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
3.95063e-05
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
3.92993e-05
|
|
|
CDAN2
|
[NCBI]
|
3.92993e-05
|
|
|
HD
|
[NCBI]
|
3.82846e-05
|
|
|
ND
|
[NCBI]
|
3.81165e-05
|
|
|
OA1
|
[NCBI]
|
3.78129e-05
|
|
|
GCKR
|
[NCBI]
|
3.77715e-05
|
|
|
ARHGEF6
|
[NCBI]
|
3.77715e-05
|
|
|
GRIK1
|
[NCBI]
|
3.77715e-05
|
|
|
CD
|
[NCBI]
|
3.73688e-05
|
|
|
ASS
|
[NCBI]
|
3.7367e-05
|
|
|
CCK
|
[NCBI]
|
3.72469e-05
|
|
|
APOC2
|
[NCBI]
|
3.68806e-05
|
|
|
FANCA
|
[NCBI]
|
3.68806e-05
|
|
|
HRPT1
|
[NCBI]
|
3.55892e-05
|
|
|
PCLD
|
[NCBI]
|
3.55892e-05
|
|
|
IBM2
|
[NCBI]
|
3.55892e-05
|
|
|
menkes disease
|
[NCBI]
|
3.55395e-05
|
|
|
MEN1
|
[NCBI]
|
3.51806e-05
|
|
|
SLC17A5
|
[NCBI]
|
3.51517e-05
|
|
|
ALS1
|
[NCBI]
|
3.47192e-05
|
|
|
PRTS
|
[NCBI]
|
3.45472e-05
|
|
|
CORD6
|
[NCBI]
|
3.45472e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
3.45472e-05
|
|
|
VAMAS1
|
[NCBI]
|
3.45472e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
3.45472e-05
|
|
|
RP18
|
[NCBI]
|
3.45472e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
3.45472e-05
|
|
|
XS
|
[NCBI]
|
3.45472e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
3.45472e-05
|
|
|
MRT2
|
[NCBI]
|
3.45472e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
3.45472e-05
|
|
|
LCA5
|
[NCBI]
|
3.45472e-05
|
|
|
DI
|
[NCBI]
|
3.45472e-05
|
|
|
EEG
|
[NCBI]
|
3.45472e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
3.45472e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
3.45472e-05
|
|
|
SPG7
|
[NCBI]
|
3.45472e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
3.45472e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
3.45472e-05
|
|
|
cardiomyopathy, dilated, autosomal recessive
|
[NCBI]
|
3.45472e-05
|
|
|
FSGS2
|
[NCBI]
|
3.45472e-05
|
|
|
resting heart rate
|
[NCBI]
|
3.45472e-05
|
|
|
ASAT
|
[NCBI]
|
3.45472e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
3.45472e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
3.45472e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
3.45472e-05
|
|
|
USH1F
|
[NCBI]
|
3.45472e-05
|
|
|
MRX30
|
[NCBI]
|
3.45472e-05
|
|
|
LI3
|
[NCBI]
|
3.45472e-05
|
|
|
AT
|
[NCBI]
|
3.45285e-05
|
|
|
MLC1
|
[NCBI]
|
3.40374e-05
|
|
|
FLCN
|
[NCBI]
|
3.40374e-05
|
|
|
MS4A2
|
[NCBI]
|
3.40374e-05
|
|
|
AFP
|
[NCBI]
|
3.39778e-05
|
|
|
SCA10
|
[NCBI]
|
3.38246e-05
|
|
|
MSS
|
[NCBI]
|
3.38246e-05
|
|
|
MVP
|
[NCBI]
|
3.37087e-05
|
|
|
PSACH
|
[NCBI]
|
3.31335e-05
|
|
|
SIX1
|
[NCBI]
|
3.30227e-05
|
|
|
KRT24
|
[NCBI]
|
3.29826e-05
|
|
|
GPR85
|
[NCBI]
|
3.29826e-05
|
|
|
PPP2R2C
|
[NCBI]
|
3.29826e-05
|
|
|
obesity, susceptibility to, on chromosome 10q
|
[NCBI]
|
3.29826e-05
|
|
|
SREB3
|
[NCBI]
|
3.29826e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
3.29826e-05
|
|
|
transmembrane 7 superfamily, member 3
|
[NCBI]
|
3.29826e-05
|
|
|
BMND8
|
[NCBI]
|
3.29826e-05
|
|
|
HMG20A
|
[NCBI]
|
3.29826e-05
|
|
|
mental retardation, x-linked, with short stature
|
[NCBI]
|
3.29826e-05
|
|
|
GPR27
|
[NCBI]
|
3.29826e-05
|
|
|
NF1
|
[NCBI]
|
3.28214e-05
|
|
|
MBP
|
[NCBI]
|
3.28099e-05
|
|
|
RIEG1
|
[NCBI]
|
3.21715e-05
|
|
|
TPM1
|
[NCBI]
|
3.20915e-05
|
|
|
XG
|
[NCBI]
|
3.20915e-05
|
|
|
alsin
|
[NCBI]
|
3.20915e-05
|
|
|
CACNA1A
|
[NCBI]
|
3.18686e-05
|
|
|
PRH1
|
[NCBI]
|
3.12314e-05
|
|
|
TECTA
|
[NCBI]
|
3.12314e-05
|
|
|
HSPD1
|
[NCBI]
|
3.12314e-05
|
|
|
F13A1
|
[NCBI]
|
3.12217e-05
|
|
|
stomatocytosis i
|
[NCBI]
|
3.10331e-05
|
|
|
donohue syndrome
|
[NCBI]
|
3.06189e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
3.06189e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
3.06189e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
3.06189e-05
|
|
|
GDAP1
|
[NCBI]
|
3.04324e-05
|
|
|
PFC
|
[NCBI]
|
3.04324e-05
|
|
|
APOA2
|
[NCBI]
|
3.04324e-05
|
|
|
COCH
|
[NCBI]
|
3.04324e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
3.04132e-05
|
|
|
APOB
|
[NCBI]
|
3.02035e-05
|
|
|
CACP
|
[NCBI]
|
2.98892e-05
|
|
|
EDM2
|
[NCBI]
|
2.98892e-05
|
|
|
IDDM10
|
[NCBI]
|
2.98892e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
2.98892e-05
|
|
|
PFIC2
|
[NCBI]
|
2.98892e-05
|
|
|
IDDM12
|
[NCBI]
|
2.98892e-05
|
|
|
NEM1
|
[NCBI]
|
2.98892e-05
|
|
|
DFNA10
|
[NCBI]
|
2.98892e-05
|
|
|
CSCD
|
[NCBI]
|
2.98892e-05
|
|
|
RTADR
|
[NCBI]
|
2.98892e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
2.98892e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
2.98892e-05
|
|
|
PGL3
|
[NCBI]
|
2.98892e-05
|
|
|
watson syndrome
|
[NCBI]
|
2.98892e-05
|
|
|
LVNC1
|
[NCBI]
|
2.98892e-05
|
|
|
DFNB2
|
[NCBI]
|
2.98892e-05
|
|
|
STL3
|
[NCBI]
|
2.98892e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
2.98892e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
2.98892e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
2.98892e-05
|
|
|
neurofibromatosis, familial spinal
|
[NCBI]
|
2.98892e-05
|
|
|
JAE
|
[NCBI]
|
2.98892e-05
|
|
|
NAIC
|
[NCBI]
|
2.98892e-05
|
|
|
DFNA13
|
[NCBI]
|
2.98892e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
2.98892e-05
|
|
|
KRS
|
[NCBI]
|
2.98892e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
2.98892e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
2.98892e-05
|
|
|
RP15
|
[NCBI]
|
2.98892e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
2.98892e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
2.98892e-05
|
|
|
MRX59
|
[NCBI]
|
2.98892e-05
|
|
|
CMD1D
|
[NCBI]
|
2.98892e-05
|
|
|
PC2
|
[NCBI]
|
2.98892e-05
|
|
|
ramon syndrome
|
[NCBI]
|
2.98892e-05
|
|
|
AIHHT
|
[NCBI]
|
2.98892e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
2.98892e-05
|
|
|
DFNA17
|
[NCBI]
|
2.98892e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
2.98892e-05
|
|
|
CDHS
|
[NCBI]
|
2.98892e-05
|
|
|
PDB1
|
[NCBI]
|
2.98892e-05
|
|
|
DRD2
|
[NCBI]
|
2.97139e-05
|
|
|
ELAC2
|
[NCBI]
|
2.96867e-05
|
|
|
LYST
|
[NCBI]
|
2.96867e-05
|
|
|
ATP1A2
|
[NCBI]
|
2.96867e-05
|
|
|
NPS
|
[NCBI]
|
2.94808e-05
|
|
|
AR
|
[NCBI]
|
2.92278e-05
|
|
|
MLC
|
[NCBI]
|
2.91575e-05
|
|
|
CLN1
|
[NCBI]
|
2.91575e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
2.91575e-05
|
|
|
KEL
|
[NCBI]
|
2.89878e-05
|
|
|
BRRS
|
[NCBI]
|
2.85775e-05
|
|
|
IL6R
|
[NCBI]
|
2.83302e-05
|
|
|
NEFL
|
[NCBI]
|
2.83302e-05
|
|
|
SPG7
|
[NCBI]
|
2.83302e-05
|
|
|
alcohol dependence
|
[NCBI]
|
2.77791e-05
|
|
|
LMX1B
|
[NCBI]
|
2.77095e-05
|
|
|
SPR
|
[NCBI]
|
2.77095e-05
|
|
|
FLT4
|
[NCBI]
|
2.77095e-05
|
|
|
FUT2
|
[NCBI]
|
2.77095e-05
|
|
|
PCDH15
|
[NCBI]
|
2.77095e-05
|
|
|
NF2
|
[NCBI]
|
2.77021e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.75166e-05
|
|
|
WNK1
|
[NCBI]
|
2.71219e-05
|
|
|
CCM
|
[NCBI]
|
2.68533e-05
|
|
|
FCMD
|
[NCBI]
|
2.68533e-05
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
2.68366e-05
|
|
|
OSCS
|
[NCBI]
|
2.68366e-05
|
|
|
MKS2
|
[NCBI]
|
2.68366e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
2.68366e-05
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
2.68366e-05
|
|
|
hemangioma, capillary infantile
|
[NCBI]
|
2.68366e-05
|
|
|
PGL2
|
[NCBI]
|
2.68366e-05
|
|
|
vestibulopathy, familial
|
[NCBI]
|
2.68366e-05
|
|
|
SCZD10
|
[NCBI]
|
2.68366e-05
|
|
|
STHAG4
|
[NCBI]
|
2.68366e-05
|
|
|
myopathy with deficiency of succinate dehydrogenase and aconitase
|
[NCBI]
|
2.68366e-05
|
|
|
macular edema, cystoid
|
[NCBI]
|
2.68366e-05
|
|
|
NNO1
|
[NCBI]
|
2.68366e-05
|
|
|
CFTR
|
[NCBI]
|
2.67926e-05
|
|
|
DFNB7
|
[NCBI]
|
2.62593e-05
|
|
|
LIS2
|
[NCBI]
|
2.62593e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
2.62593e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
2.62593e-05
|
|
|
DFNA4
|
[NCBI]
|
2.62593e-05
|
|
|
MRXSL
|
[NCBI]
|
2.62593e-05
|
|
|
HDL1
|
[NCBI]
|
2.62593e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
2.62593e-05
|
|
|
CCM2
|
[NCBI]
|
2.62593e-05
|
|
|
CGL1
|
[NCBI]
|
2.62593e-05
|
|
|
MONA
|
[NCBI]
|
2.62593e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
2.62593e-05
|
|
|
MRT1
|
[NCBI]
|
2.62593e-05
|
|
|
DFNB18
|
[NCBI]
|
2.62593e-05
|
|
|
CNA2
|
[NCBI]
|
2.62593e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
2.62593e-05
|
|
|
peters anomaly
|
[NCBI]
|
2.62593e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
2.62593e-05
|
|
|
RP14
|
[NCBI]
|
2.62593e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
2.62593e-05
|
|
|
cataract, lamellar
|
[NCBI]
|
2.62593e-05
|
|
|
EVR4
|
[NCBI]
|
2.62593e-05
|
|
|
leukodystrophy, adult-onset, autosomal dominant
|
[NCBI]
|
2.62593e-05
|
|
|
RP17
|
[NCBI]
|
2.62593e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
2.60335e-05
|
|
|
ATR
|
[NCBI]
|
2.55275e-05
|
|
|
TCOF1
|
[NCBI]
|
2.55275e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
2.52441e-05
|
|
|
ARPKD
|
[NCBI]
|
2.52315e-05
|
|
|
HHIP
|
[NCBI]
|
2.47583e-05
|
|
|
ZFAT1
|
[NCBI]
|
2.47583e-05
|
|
|
GPR92
|
[NCBI]
|
2.47583e-05
|
|
|
NDUFV3
|
[NCBI]
|
2.47583e-05
|
|
|
TTC8
|
[NCBI]
|
2.47583e-05
|
|
|
ADAM29
|
[NCBI]
|
2.47583e-05
|
|
|
respiratory rhythmicity in sleep
|
[NCBI]
|
2.47583e-05
|
|
|
TBCD
|
[NCBI]
|
2.47583e-05
|
|
|
CHRM4
|
[NCBI]
|
2.47583e-05
|
|
|
PCDH9
|
[NCBI]
|
2.47583e-05
|
|
|
CTPP4
|
[NCBI]
|
2.47583e-05
|
|
|
TMEM142C
|
[NCBI]
|
2.47583e-05
|
|
|
NEURL
|
[NCBI]
|
2.47583e-05
|
|
|
MMP24
|
[NCBI]
|
2.47583e-05
|
|
|
ZC3H12D
|
[NCBI]
|
2.47583e-05
|
|
|
DCTN3
|
[NCBI]
|
2.47583e-05
|
|
|
SSBP1
|
[NCBI]
|
2.47583e-05
|
|
|
GABRG1
|
[NCBI]
|
2.47583e-05
|
|
|
TMEM142B
|
[NCBI]
|
2.47583e-05
|
|
|
PRKAR2A
|
[NCBI]
|
2.47583e-05
|
|
|
MPP4
|
[NCBI]
|
2.47583e-05
|
|
|
HYLS1
|
[NCBI]
|
2.47583e-05
|
|
|
OTOA
|
[NCBI]
|
2.47583e-05
|
|
|
SPG11
|
[NCBI]
|
2.47583e-05
|
|
|
LAPTM5
|
[NCBI]
|
2.47583e-05
|
|
|
KCNQ1DN
|
[NCBI]
|
2.47583e-05
|
|
|
OPA3
|
[NCBI]
|
2.47583e-05
|
|
|
ZNF79
|
[NCBI]
|
2.47583e-05
|
|
|
ERV3
|
[NCBI]
|
2.47583e-05
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
2.47583e-05
|
|
|
CVID
|
[NCBI]
|
2.47507e-05
|
|
|
PTEN
|
[NCBI]
|
2.46954e-05
|
|
|
LEP
|
[NCBI]
|
2.4182e-05
|
|
|
CTSK
|
[NCBI]
|
2.37118e-05
|
|
|
NPPA
|
[NCBI]
|
2.35756e-05
|
|
|
BBS
|
[NCBI]
|
2.34869e-05
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
2.33087e-05
|
|
|
CLN6
|
[NCBI]
|
2.33087e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
2.33087e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
2.33087e-05
|
|
|
NEM2
|
[NCBI]
|
2.33087e-05
|
|
|
CO
|
[NCBI]
|
2.33087e-05
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
2.33087e-05
|
|
|
ALS4
|
[NCBI]
|
2.33087e-05
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
2.33087e-05
|
|
|
pierson syndrome
|
[NCBI]
|
2.33087e-05
|
|
|
FSGS1
|
[NCBI]
|
2.33087e-05
|
|
|
FHL2
|
[NCBI]
|
2.33087e-05
|
|
|
LGMD2J
|
[NCBI]
|
2.33087e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
2.33087e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
2.33087e-05
|
|
|
CCM3
|
[NCBI]
|
2.33087e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
2.33087e-05
|
|
|
SPMM
|
[NCBI]
|
2.33087e-05
|
|
|
CPVT
|
[NCBI]
|
2.33087e-05
|
|
|
CORD3
|
[NCBI]
|
2.33087e-05
|
|
|
EAD
|
[NCBI]
|
2.33087e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
2.33087e-05
|
|
|
SLC17A7
|
[NCBI]
|
2.33021e-05
|
|
|
TNNT2
|
[NCBI]
|
2.33021e-05
|
|
|
IFNGR1
|
[NCBI]
|
2.33021e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
2.29668e-05
|
|
|
KRT14
|
[NCBI]
|
2.29077e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.22122e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.21604e-05
|
|
|
ATRX
|
[NCBI]
|
2.1913e-05
|
|
|
DCN
|
[NCBI]
|
2.18058e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
2.17884e-05
|
|
|
MPZ
|
[NCBI]
|
2.17061e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.17061e-05
|
|
|
MYOZ2
|
[NCBI]
|
2.16686e-05
|
|
|
HS1BP3
|
[NCBI]
|
2.16686e-05
|
|
|
STOX1
|
[NCBI]
|
2.16686e-05
|
|
|
ERDA1
|
[NCBI]
|
2.16686e-05
|
|
|
GNPTG
|
[NCBI]
|
2.16686e-05
|
|
|
MMP17
|
[NCBI]
|
2.16686e-05
|
|
|
CDH16
|
[NCBI]
|
2.16686e-05
|
|
|
RRH
|
[NCBI]
|
2.16686e-05
|
|
|
INA
|
[NCBI]
|
2.16686e-05
|
|
|
RHOD
|
[NCBI]
|
2.16686e-05
|
|
|
acidic cluster protein, 33-kd
|
[NCBI]
|
2.16686e-05
|
|
|
GPR78
|
[NCBI]
|
2.16686e-05
|
|
|
EVER2
|
[NCBI]
|
2.16686e-05
|
|
|
EPR1
|
[NCBI]
|
2.16686e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
2.16686e-05
|
|
|
CPSF1
|
[NCBI]
|
2.16686e-05
|
|
|
BARHL1
|
[NCBI]
|
2.16686e-05
|
|
|
OTOG
|
[NCBI]
|
2.16686e-05
|
|
|
P2RX5
|
[NCBI]
|
2.16686e-05
|
|
|
CCT4
|
[NCBI]
|
2.16686e-05
|
|
|
RRM2B
|
[NCBI]
|
2.16686e-05
|
|
|
IGLP1
|
[NCBI]
|
2.16686e-05
|
|
|
CYP2F1
|
[NCBI]
|
2.16686e-05
|
|
|
CPSF2
|
[NCBI]
|
2.16686e-05
|
|
|
HMG20B
|
[NCBI]
|
2.16686e-05
|
|
|
TMEM16E
|
[NCBI]
|
2.16686e-05
|
|
|
CERKL
|
[NCBI]
|
2.16686e-05
|
|
|
LCA5
|
[NCBI]
|
2.16686e-05
|
|
|
CACNG1
|
[NCBI]
|
2.16686e-05
|
|
|
SAMD9
|
[NCBI]
|
2.16686e-05
|
|
|
XCR1
|
[NCBI]
|
2.16686e-05
|
|
|
GABRG3
|
[NCBI]
|
2.16686e-05
|
|
|
KCNRG
|
[NCBI]
|
2.16686e-05
|
|
|
MKS1
|
[NCBI]
|
2.15749e-05
|
|
|
KRT5
|
[NCBI]
|
2.14628e-05
|
|
|
DYSF
|
[NCBI]
|
2.14628e-05
|
|
|
MN
|
[NCBI]
|
2.14628e-05
|
|
|
CLCN1
|
[NCBI]
|
2.11308e-05
|
|
|
STL1
|
[NCBI]
|
2.09103e-05
|
|
|
HHC1
|
[NCBI]
|
2.09103e-05
|
|
|
TRMA
|
[NCBI]
|
2.0841e-05
|
|
|
PIL
|
[NCBI]
|
2.0841e-05
|
|
|
CHED2
|
[NCBI]
|
2.0841e-05
|
|
|
PHA2
|
[NCBI]
|
2.0841e-05
|
|
|
PARK7
|
[NCBI]
|
2.0841e-05
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
2.0841e-05
|
|
|
mast cell disease
|
[NCBI]
|
2.0841e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
2.0841e-05
|
|
|
MCOPS2
|
[NCBI]
|
2.0841e-05
|
|
|
ACHM3
|
[NCBI]
|
2.0841e-05
|
|
|
EPD
|
[NCBI]
|
2.0841e-05
|
|
|
CMT4B1
|
[NCBI]
|
2.0841e-05
|
|
|
EVR2
|
[NCBI]
|
2.0841e-05
|
|
|
MFS2
|
[NCBI]
|
2.0841e-05
|
|
|
myopathy, myosin storage
|
[NCBI]
|
2.0841e-05
|
|
|
AIH2
|
[NCBI]
|
2.0841e-05
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
2.0841e-05
|
|
|
BPP
|
[NCBI]
|
2.0841e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
2.0841e-05
|
|
|
PARK4
|
[NCBI]
|
2.0841e-05
|
|
|
MRX9
|
[NCBI]
|
2.0841e-05
|
|
|
SLEB1
|
[NCBI]
|
2.0841e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
2.0841e-05
|
|
|
PEPD
|
[NCBI]
|
2.0809e-05
|
|
|
SPG4
|
[NCBI]
|
2.0809e-05
|
|
|
TYRP1
|
[NCBI]
|
2.0497e-05
|
|
|
FPLD2
|
[NCBI]
|
1.99554e-05
|
|
|
SLC26A4
|
[NCBI]
|
1.99001e-05
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
1.97086e-05
|
|
|
LIPH
|
[NCBI]
|
1.96703e-05
|
|
|
PLEKHA1
|
[NCBI]
|
1.96703e-05
|
|
|
PHLDA1
|
[NCBI]
|
1.96703e-05
|
|
|
GUCY2F
|
[NCBI]
|
1.96703e-05
|
|
|
BBS2
|
[NCBI]
|
1.96703e-05
|
|
|
TRSP
|
[NCBI]
|
1.96703e-05
|
|
|
EFHC1
|
[NCBI]
|
1.96703e-05
|
|
|
OSR2
|
[NCBI]
|
1.96703e-05
|
|
|
EVER1
|
[NCBI]
|
1.96703e-05
|
|
|
SOX21
|
[NCBI]
|
1.96703e-05
|
|
|
TSNAX
|
[NCBI]
|
1.96703e-05
|
|
|
CLK2
|
[NCBI]
|
1.96703e-05
|
|
|
GAPDHS
|
[NCBI]
|
1.96703e-05
|
|
|
PRPF8
|
[NCBI]
|
1.96703e-05
|
|
|
PFN2
|
[NCBI]
|
1.96703e-05
|
|
|
ANGPTL2
|
[NCBI]
|
1.96703e-05
|
|
|
CTNNA3
|
[NCBI]
|
1.96703e-05
|
|
|
KCNK6
|
[NCBI]
|
1.96703e-05
|
|
|
CTSH
|
[NCBI]
|
1.96703e-05
|
|
|
minor histocompatibility antigen ha-2
|
[NCBI]
|
1.96703e-05
|
|
|
GPD1L
|
[NCBI]
|
1.96703e-05
|
|
|
CRI1
|
[NCBI]
|
1.96703e-05
|
|
|
RP9
|
[NCBI]
|
1.96703e-05
|
|
|
ZNF81
|
[NCBI]
|
1.96703e-05
|
|
|
AXIN2
|
[NCBI]
|
1.96703e-05
|
|
|
RPL12
|
[NCBI]
|
1.96703e-05
|
|
|
ADRBK2
|
[NCBI]
|
1.96703e-05
|
|
|
GABRB1
|
[NCBI]
|
1.96703e-05
|
|
|
XPR1
|
[NCBI]
|
1.96703e-05
|
|
|
NOD2
|
[NCBI]
|
1.93362e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
1.90656e-05
|
|
|
EDN1
|
[NCBI]
|
1.90656e-05
|
|
|
SGBS1
|
[NCBI]
|
1.90451e-05
|
|
|
FBN1
|
[NCBI]
|
1.88781e-05
|
|
|
PLSJ
|
[NCBI]
|
1.87342e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
1.87342e-05
|
|
|
FTD3
|
[NCBI]
|
1.87342e-05
|
|
|
SYNS1
|
[NCBI]
|
1.87342e-05
|
|
|
CMH4
|
[NCBI]
|
1.87342e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.87342e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
1.87342e-05
|
|
|
CMT4B2
|
[NCBI]
|
1.87342e-05
|
|
|
SYM1
|
[NCBI]
|
1.87342e-05
|
|
|
currarino syndrome
|
[NCBI]
|
1.87342e-05
|
|
|
INAD1
|
[NCBI]
|
1.87342e-05
|
|
|
DFNA9
|
[NCBI]
|
1.87342e-05
|
|
|
MODY2
|
[NCBI]
|
1.87342e-05
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
1.87342e-05
|
|
|
LRS1
|
[NCBI]
|
1.87342e-05
|
|
|
CMM
|
[NCBI]
|
1.84718e-05
|
|
|
HSCR1
|
[NCBI]
|
1.83457e-05
|
|
|
AIS
|
[NCBI]
|
1.83247e-05
|
|
|
CORT
|
[NCBI]
|
1.81903e-05
|
|
|
SLC25A19
|
[NCBI]
|
1.81903e-05
|
|
|
MAP3K13
|
[NCBI]
|
1.81903e-05
|
|
|
PRKCSH
|
[NCBI]
|
1.81903e-05
|
|
|
GLMN
|
[NCBI]
|
1.81903e-05
|
|
|
A1BG
|
[NCBI]
|
1.81903e-05
|
|
|
CDK5RAP2
|
[NCBI]
|
1.81903e-05
|
|
|
CCM2
|
[NCBI]
|
1.81903e-05
|
|
|
ATP6AP2
|
[NCBI]
|
1.81903e-05
|
|
|
g30 gene
|
[NCBI]
|
1.81903e-05
|
|
|
STRC
|
[NCBI]
|
1.81903e-05
|
|
|
PHF8
|
[NCBI]
|
1.81903e-05
|
|
|
KCNC3
|
[NCBI]
|
1.81903e-05
|
|
|
ACTR1A
|
[NCBI]
|
1.81903e-05
|
|
|
COQ2
|
[NCBI]
|
1.81903e-05
|
|
|
SAA4
|
[NCBI]
|
1.81903e-05
|
|
|
AP1S2
|
[NCBI]
|
1.81903e-05
|
|
|
SENP2
|
[NCBI]
|
1.81903e-05
|
|
|
MCAM
|
[NCBI]
|
1.81903e-05
|
|
|
ADAM33
|
[NCBI]
|
1.81903e-05
|
|
|
PDGFC
|
[NCBI]
|
1.81903e-05
|
|
|
IRAK3
|
[NCBI]
|
1.81903e-05
|
|
|
CDR1
|
[NCBI]
|
1.81903e-05
|
|
|
YARS
|
[NCBI]
|
1.81903e-05
|
|
|
HRC
|
[NCBI]
|
1.81903e-05
|
|
|
HSPA6
|
[NCBI]
|
1.81903e-05
|
|
|
FXYD2
|
[NCBI]
|
1.81903e-05
|
|
|
SORCS1
|
[NCBI]
|
1.81903e-05
|
|
|
PRKAR1B
|
[NCBI]
|
1.81903e-05
|
|
|
GRM7
|
[NCBI]
|
1.81903e-05
|
|
|
VPS33B
|
[NCBI]
|
1.81903e-05
|
|
|
LNX1
|
[NCBI]
|
1.81903e-05
|
|
|
CRYGS
|
[NCBI]
|
1.81903e-05
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
1.81903e-05
|
|
|
INSRR
|
[NCBI]
|
1.81903e-05
|
|
|
PLA2G6
|
[NCBI]
|
1.81903e-05
|
|
|
GRM4
|
[NCBI]
|
1.81903e-05
|
|
|
INS
|
[NCBI]
|
1.79717e-05
|
|
|
ATRX
|
[NCBI]
|
1.758e-05
|
|
|
TCF7L2
|
[NCBI]
|
1.73527e-05
|
|
|
CMD1A
|
[NCBI]
|
1.73472e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
1.73472e-05
|
|
|
ESD
|
[NCBI]
|
1.71277e-05
|
|
|
EIF2B4
|
[NCBI]
|
1.70157e-05
|
|
|
MYH8
|
[NCBI]
|
1.70157e-05
|
|
|
PLOD3
|
[NCBI]
|
1.70157e-05
|
|
|
HSN2
|
[NCBI]
|
1.70157e-05
|
|
|
PCDH8
|
[NCBI]
|
1.70157e-05
|
|
|
MYL3
|
[NCBI]
|
1.70157e-05
|
|
|
PMPCB
|
[NCBI]
|
1.70157e-05
|
|
|
MOCS1
|
[NCBI]
|
1.70157e-05
|
|
|
NLRP7
|
[NCBI]
|
1.70157e-05
|
|
|
IGFBP4
|
[NCBI]
|
1.70157e-05
|
|
|
CHE2
|
[NCBI]
|
1.70157e-05
|
|
|
PLUNC
|
[NCBI]
|
1.70157e-05
|
|
|
HTR7
|
[NCBI]
|
1.70157e-05
|
|
|
SLC22A7
|
[NCBI]
|
1.70157e-05
|
|
|
NTF5
|
[NCBI]
|
1.70157e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.70157e-05
|
|
|
P2RX4
|
[NCBI]
|
1.70157e-05
|
|
|
TMEM142A
|
[NCBI]
|
1.70157e-05
|
|
|
CCBP2
|
[NCBI]
|
1.70157e-05
|
|
|
DLG5
|
[NCBI]
|
1.70157e-05
|
|
|
ANK2
|
[NCBI]
|
1.70157e-05
|
|
|
BTNL2
|
[NCBI]
|
1.70157e-05
|
|
|
FTSJ1
|
[NCBI]
|
1.70157e-05
|
|
|
KIF5A
|
[NCBI]
|
1.70157e-05
|
|
|
SULT2A1
|
[NCBI]
|
1.70157e-05
|
|
|
MYCL1
|
[NCBI]
|
1.70157e-05
|
|
|
SLC4A11
|
[NCBI]
|
1.70157e-05
|
|
|
DDX11
|
[NCBI]
|
1.70157e-05
|
|
|
MYL2
|
[NCBI]
|
1.70157e-05
|
|
|
HMCN1
|
[NCBI]
|
1.70157e-05
|
|
|
NDST2
|
[NCBI]
|
1.70157e-05
|
|
|
FUCA2
|
[NCBI]
|
1.70157e-05
|
|
|
PKD2L1
|
[NCBI]
|
1.70157e-05
|
|
|
ZNF384
|
[NCBI]
|
1.70157e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
1.70157e-05
|
|
|
CRYBB3
|
[NCBI]
|
1.70157e-05
|
|
|
PI7
|
[NCBI]
|
1.70157e-05
|
|
|
HK3
|
[NCBI]
|
1.70157e-05
|
|
|
g72 gene
|
[NCBI]
|
1.70157e-05
|
|
|
PRKAR2B
|
[NCBI]
|
1.70157e-05
|
|
|
SEC23A
|
[NCBI]
|
1.70157e-05
|
|
|
SBDS
|
[NCBI]
|
1.70157e-05
|
|
|
CDKN2A
|
[NCBI]
|
1.70115e-05
|
|
|
WAS
|
[NCBI]
|
1.69135e-05
|
|
|
FGF23
|
[NCBI]
|
1.69135e-05
|
|
|
NETH
|
[NCBI]
|
1.69077e-05
|
|
|
PARK1
|
[NCBI]
|
1.69077e-05
|
|
|
schwannomatosis
|
[NCBI]
|
1.69077e-05
|
|
|
EBS2
|
[NCBI]
|
1.69077e-05
|
|
|
HCHWAD
|
[NCBI]
|
1.69077e-05
|
|
|
HFE4
|
[NCBI]
|
1.69077e-05
|
|
|
JWS
|
[NCBI]
|
1.69077e-05
|
|
|
epstein syndrome
|
[NCBI]
|
1.69077e-05
|
|
|
CSNB2A
|
[NCBI]
|
1.69077e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
1.69077e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
1.69077e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
1.69077e-05
|
|
|
CMT4D
|
[NCBI]
|
1.69077e-05
|
|
|
NYS1
|
[NCBI]
|
1.69077e-05
|
|
|
FMD
|
[NCBI]
|
1.69077e-05
|
|
|
HIGM1
|
[NCBI]
|
1.65547e-05
|
|
|
CDPX2
|
[NCBI]
|
1.65547e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.65547e-05
|
|
|
INSR
|
[NCBI]
|
1.61197e-05
|
|
|
CLCN3
|
[NCBI]
|
1.60428e-05
|
|
|
NHS
|
[NCBI]
|
1.60428e-05
|
|
|
PMX1
|
[NCBI]
|
1.60428e-05
|
|
|
MUC3A
|
[NCBI]
|
1.60428e-05
|
|
|
CRYBA4
|
[NCBI]
|
1.60428e-05
|
|
|
LHX8
|
[NCBI]
|
1.60428e-05
|
|
|
CTNNA2
|
[NCBI]
|
1.60428e-05
|
|
|
PRPS2
|
[NCBI]
|
1.60428e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
1.60428e-05
|
|
|
SORL1
|
[NCBI]
|
1.60428e-05
|
|
|
CRYM
|
[NCBI]
|
1.60428e-05
|
|
|
CCR9
|
[NCBI]
|
1.60428e-05
|
|
|
LCP2
|
[NCBI]
|
1.60428e-05
|
|
|
P2RX1
|
[NCBI]
|
1.60428e-05
|
|
|
HSF4
|
[NCBI]
|
1.60428e-05
|
|
|
WHRN
|
[NCBI]
|
1.60428e-05
|
|
|
GLP1R
|
[NCBI]
|
1.60428e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
1.60428e-05
|
|
|
TNNT1
|
[NCBI]
|
1.60428e-05
|
|
|
IL1RAPL1
|
[NCBI]
|
1.60428e-05
|
|
|
NPHP4
|
[NCBI]
|
1.60428e-05
|
|
|
SART3
|
[NCBI]
|
1.60428e-05
|
|
|
OMP
|
[NCBI]
|
1.60126e-05
|
|
|
OPA1
|
[NCBI]
|
1.57969e-05
|
|
|
KIT
|
[NCBI]
|
1.57045e-05
|
|
|
MYH7
|
[NCBI]
|
1.57045e-05
|
|
|
A2M
|
[NCBI]
|
1.55172e-05
|
|
|
PLP1
|
[NCBI]
|
1.55172e-05
|
|
|
REN
|
[NCBI]
|
1.53335e-05
|
|
|
PSEN2
|
[NCBI]
|
1.53335e-05
|
|
|
GNRHR
|
[NCBI]
|
1.53335e-05
|
|
|
ASMD
|
[NCBI]
|
1.53051e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
1.53051e-05
|
|
|
LGMD1A
|
[NCBI]
|
1.53051e-05
|
|
|
IRID2
|
[NCBI]
|
1.53051e-05
|
|
|
CDL1
|
[NCBI]
|
1.53051e-05
|
|
|
BDC
|
[NCBI]
|
1.53051e-05
|
|
|
IRID1
|
[NCBI]
|
1.53051e-05
|
|
|
feingold syndrome
|
[NCBI]
|
1.53051e-05
|
|
|
BOS1
|
[NCBI]
|
1.53051e-05
|
|
|
brody myopathy
|
[NCBI]
|
1.53051e-05
|
|
|
SCA14
|
[NCBI]
|
1.53051e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
1.53051e-05
|
|
|
DRRS
|
[NCBI]
|
1.53051e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
1.53051e-05
|
|
|
NIPBL
|
[NCBI]
|
1.52133e-05
|
|
|
TNNC1
|
[NCBI]
|
1.52133e-05
|
|
|
HLXB9
|
[NCBI]
|
1.52133e-05
|
|
|
LAMB2
|
[NCBI]
|
1.52133e-05
|
|
|
S100A7
|
[NCBI]
|
1.52133e-05
|
|
|
CAMK2G
|
[NCBI]
|
1.52133e-05
|
|
|
KCNJ3
|
[NCBI]
|
1.52133e-05
|
|
|
USH3A
|
[NCBI]
|
1.52133e-05
|
|
|
PTGFR
|
[NCBI]
|
1.52133e-05
|
|
|
VKORC1
|
[NCBI]
|
1.52133e-05
|
|
|
TLX3
|
[NCBI]
|
1.52133e-05
|
|
|
TMPRSS3
|
[NCBI]
|
1.52133e-05
|
|
|
GLRA2
|
[NCBI]
|
1.52133e-05
|
|
|
CLDN14
|
[NCBI]
|
1.52133e-05
|
|
|
CENPJ
|
[NCBI]
|
1.52133e-05
|
|
|
PSTPIP1
|
[NCBI]
|
1.52133e-05
|
|
|
SLC9A1
|
[NCBI]
|
1.52133e-05
|
|
|
HSPA2
|
[NCBI]
|
1.52133e-05
|
|
|
FLNC
|
[NCBI]
|
1.52133e-05
|
|
|
COLQ
|
[NCBI]
|
1.52133e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.52133e-05
|
|
|
ISL1
|
[NCBI]
|
1.52133e-05
|
|
|
CLCN2
|
[NCBI]
|
1.52133e-05
|
|
|
TMC1
|
[NCBI]
|
1.52133e-05
|
|
|
CRYBB1
|
[NCBI]
|
1.52133e-05
|
|
|
CHIT1
|
[NCBI]
|
1.52133e-05
|
|
|
CNGA3
|
[NCBI]
|
1.52133e-05
|
|
|
SLC22A4
|
[NCBI]
|
1.52133e-05
|
|
|
RPGR
|
[NCBI]
|
1.51534e-05
|
|
|
AVSD
|
[NCBI]
|
1.51478e-05
|
|
|
LFS1
|
[NCBI]
|
1.50719e-05
|
|
|
COH1
|
[NCBI]
|
1.50719e-05
|
|
|
ATS
|
[NCBI]
|
1.50719e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.50719e-05
|
|
|
SLC11A1
|
[NCBI]
|
1.48032e-05
|
|
|
GC
|
[NCBI]
|
1.47984e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.46922e-05
|
|
|
GCLM
|
[NCBI]
|
1.44909e-05
|
|
|
SACS
|
[NCBI]
|
1.44909e-05
|
|
|
RCV1
|
[NCBI]
|
1.44909e-05
|
|
|
SLC2A8
|
[NCBI]
|
1.44909e-05
|
|
|
EDNRA
|
[NCBI]
|
1.44909e-05
|
|
|
CRLF1
|
[NCBI]
|
1.44909e-05
|
|
|
PTF1A
|
[NCBI]
|
1.44909e-05
|
|
|
PRH2
|
[NCBI]
|
1.44909e-05
|
|
|
SDC3
|
[NCBI]
|
1.44909e-05
|
|
|
BSCL2
|
[NCBI]
|
1.44909e-05
|
|
|
FRZB
|
[NCBI]
|
1.44909e-05
|
|
|
FGF20
|
[NCBI]
|
1.44909e-05
|
|
|
OPHN1
|
[NCBI]
|
1.44909e-05
|
|
|
GNAL
|
[NCBI]
|
1.44909e-05
|
|
|
PPP2R2B
|
[NCBI]
|
1.44909e-05
|
|
|
hemojuvelin
|
[NCBI]
|
1.44909e-05
|
|
|
CMH
|
[NCBI]
|
1.43619e-05
|
|
|
SPTA1
|
[NCBI]
|
1.43018e-05
|
|
|
ECA1
|
[NCBI]
|
1.42982e-05
|
|
|
acetabular dysplasia
|
[NCBI]
|
1.42982e-05
|
|
|
MENOQ1
|
[NCBI]
|
1.42982e-05
|
|
|
kohlschutter-tonz syndrome
|
[NCBI]
|
1.42982e-05
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
1.42982e-05
|
|
|
AUTS4
|
[NCBI]
|
1.42982e-05
|
|
|
DBQD
|
[NCBI]
|
1.42982e-05
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
1.42982e-05
|
|
|
MYMY1
|
[NCBI]
|
1.42982e-05
|
|
|
TAPVR1
|
[NCBI]
|
1.42982e-05
|
|
|
ELN
|
[NCBI]
|
1.39822e-05
|
|
|
THC1
|
[NCBI]
|
1.38855e-05
|
|
|
SFD
|
[NCBI]
|
1.38855e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
1.38855e-05
|
|
|
MTC
|
[NCBI]
|
1.38855e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
1.38855e-05
|
|
|
CDA
|
[NCBI]
|
1.38855e-05
|
|
|
ALUNC
|
[NCBI]
|
1.38855e-05
|
|
|
LGMD2D
|
[NCBI]
|
1.38855e-05
|
|
|
IHPS1
|
[NCBI]
|
1.38855e-05
|
|
|
DA2B
|
[NCBI]
|
1.38855e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
1.38855e-05
|
|
|
LGMD2H
|
[NCBI]
|
1.38855e-05
|
|
|
PPD2
|
[NCBI]
|
1.38855e-05
|
|
|
SNDI
|
[NCBI]
|
1.38855e-05
|
|
|
pycnodysostosis
|
[NCBI]
|
1.38855e-05
|
|
|
TRPC6
|
[NCBI]
|
1.38518e-05
|
|
|
RP1
|
[NCBI]
|
1.38518e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.38518e-05
|
|
|
GUCA1A
|
[NCBI]
|
1.38518e-05
|
|
|
CLDN16
|
[NCBI]
|
1.38518e-05
|
|
|
BBS4
|
[NCBI]
|
1.38518e-05
|
|
|
SLC17A8
|
[NCBI]
|
1.38518e-05
|
|
|
SLC19A2
|
[NCBI]
|
1.38518e-05
|
|
|
LITAF
|
[NCBI]
|
1.38518e-05
|
|
|
AIP
|
[NCBI]
|
1.38518e-05
|
|
|
GCNT2
|
[NCBI]
|
1.38518e-05
|
|
|
GRHL3
|
[NCBI]
|
1.38518e-05
|
|
|
TUB
|
[NCBI]
|
1.38518e-05
|
|
|
CNGB3
|
[NCBI]
|
1.38518e-05
|
|
|
PTGER2
|
[NCBI]
|
1.38518e-05
|
|
|
ZIC2
|
[NCBI]
|
1.38518e-05
|
|
|
TTC10
|
[NCBI]
|
1.38518e-05
|
|
|
EYA4
|
[NCBI]
|
1.38518e-05
|
|
|
ALMS1
|
[NCBI]
|
1.38518e-05
|
|
|
TACSTD2
|
[NCBI]
|
1.38518e-05
|
|
|
NCAM1
|
[NCBI]
|
1.38518e-05
|
|
|
SOS1
|
[NCBI]
|
1.38518e-05
|
|
|
G6PD
|
[NCBI]
|
1.38492e-05
|
|
|
BTHS
|
[NCBI]
|
1.3713e-05
|
|
|
BWS
|
[NCBI]
|
1.37039e-05
|
|
|
APOD
|
[NCBI]
|
1.33752e-05
|
|
|
FGFR2
|
[NCBI]
|
1.3356e-05
|
|
|
WARS
|
[NCBI]
|
1.32792e-05
|
|
|
PEPC
|
[NCBI]
|
1.32792e-05
|
|
|
SAA2
|
[NCBI]
|
1.32792e-05
|
|
|
FACL4
|
[NCBI]
|
1.32792e-05
|
|
|
NPPB
|
[NCBI]
|
1.32792e-05
|
|
|
PRKAA2
|
[NCBI]
|
1.32792e-05
|
|
|
CYLD1
|
[NCBI]
|
1.32792e-05
|
|
|
LIM2
|
[NCBI]
|
1.32792e-05
|
|
|
FGF18
|
[NCBI]
|
1.32792e-05
|
|
|
STXBP1
|
[NCBI]
|
1.32792e-05
|
|
|
MUC2
|
[NCBI]
|
1.32792e-05
|
|
|
LAMA3
|
[NCBI]
|
1.32792e-05
|
|
|
HSD17B10
|
[NCBI]
|
1.32792e-05
|
|
|
AMN
|
[NCBI]
|
1.32792e-05
|
|
|
AAAS
|
[NCBI]
|
1.32792e-05
|
|
|
LAMC1
|
[NCBI]
|
1.32792e-05
|
|
|
GATA2
|
[NCBI]
|
1.32792e-05
|
|
|
SGKL
|
[NCBI]
|
1.32792e-05
|
|
|
RORA
|
[NCBI]
|
1.32792e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
1.32524e-05
|
|
|
SDS
|
[NCBI]
|
1.32524e-05
|
|
|
PAX3
|
[NCBI]
|
1.32297e-05
|
|
|
HPS
|
[NCBI]
|
1.31035e-05
|
|
|
FOP
|
[NCBI]
|
1.3076e-05
|
|
|
MYO15A
|
[NCBI]
|
1.27609e-05
|
|
|
KRT17
|
[NCBI]
|
1.27609e-05
|
|
|
SAG
|
[NCBI]
|
1.27609e-05
|
|
|
CKM
|
[NCBI]
|
1.27609e-05
|
|
|
POLB
|
[NCBI]
|
1.27609e-05
|
|
|
GOT2
|
[NCBI]
|
1.27609e-05
|
|
|
HPS1
|
[NCBI]
|
1.27609e-05
|
|
|
SOST
|
[NCBI]
|
1.27609e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.27609e-05
|
|
|
PAX9
|
[NCBI]
|
1.27609e-05
|
|
|
ITPR1
|
[NCBI]
|
1.27609e-05
|
|
|
NLRP3
|
[NCBI]
|
1.27609e-05
|
|
|
POU3F4
|
[NCBI]
|
1.27609e-05
|
|
|
FUT3
|
[NCBI]
|
1.27609e-05
|
|
|
RAB7
|
[NCBI]
|
1.27609e-05
|
|
|
TRIM24
|
[NCBI]
|
1.27609e-05
|
|
|
KCNQ4
|
[NCBI]
|
1.27609e-05
|
|
|
ZNF9
|
[NCBI]
|
1.27609e-05
|
|
|
MRX1
|
[NCBI]
|
1.27608e-05
|
|
|
MFS
|
[NCBI]
|
1.27142e-05
|
|
|
CDGG1
|
[NCBI]
|
1.26182e-05
|
|
|
ACCPN
|
[NCBI]
|
1.26182e-05
|
|
|
THC2
|
[NCBI]
|
1.26182e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
1.26182e-05
|
|
|
autoimmune disease
|
[NCBI]
|
1.26182e-05
|
|
|
NM
|
[NCBI]
|
1.26182e-05
|
|
|
USH3
|
[NCBI]
|
1.26182e-05
|
|
|
DSMA1
|
[NCBI]
|
1.26182e-05
|
|
|
RENS1
|
[NCBI]
|
1.26182e-05
|
|
|
GRTH
|
[NCBI]
|
1.26182e-05
|
|
|
FTNS
|
[NCBI]
|
1.26182e-05
|
|
|
NCIE1
|
[NCBI]
|
1.26182e-05
|
|
|
AEZ
|
[NCBI]
|
1.26182e-05
|
|
|
BMD
|
[NCBI]
|
1.24654e-05
|
|
|
MATN3
|
[NCBI]
|
1.22879e-05
|
|
|
ASCL1
|
[NCBI]
|
1.22879e-05
|
|
|
F13B
|
[NCBI]
|
1.22879e-05
|
|
|
COL6A2
|
[NCBI]
|
1.22879e-05
|
|
|
SPINK5
|
[NCBI]
|
1.22879e-05
|
|
|
PRKAG2
|
[NCBI]
|
1.22879e-05
|
|
|
ADD1
|
[NCBI]
|
1.22879e-05
|
|
|
RIMS1
|
[NCBI]
|
1.22879e-05
|
|
|
NDRG1
|
[NCBI]
|
1.22879e-05
|
|
|
SALL4
|
[NCBI]
|
1.22879e-05
|
|
|
TFE3
|
[NCBI]
|
1.22879e-05
|
|
|
COL6A3
|
[NCBI]
|
1.22879e-05
|
|
|
SIX3
|
[NCBI]
|
1.22879e-05
|
|
|
BCL2L11
|
[NCBI]
|
1.22879e-05
|
|
|
PAK3
|
[NCBI]
|
1.22879e-05
|
|
|
PKM2
|
[NCBI]
|
1.22879e-05
|
|
|
ART4
|
[NCBI]
|
1.22879e-05
|
|
|
APOE
|
[NCBI]
|
1.21299e-05
|
|
|
SNCA
|
[NCBI]
|
1.18945e-05
|
|
|
HSAN3
|
[NCBI]
|
1.18799e-05
|
|
|
GARS
|
[NCBI]
|
1.18531e-05
|
|
|
ACTG1
|
[NCBI]
|
1.18531e-05
|
|
|
MCOLN1
|
[NCBI]
|
1.18531e-05
|
|
|
C5R1
|
[NCBI]
|
1.18531e-05
|
|
|
IKBKAP
|
[NCBI]
|
1.18531e-05
|
|
|
HLA-C
|
[NCBI]
|
1.18531e-05
|
|
|
ATXN2
|
[NCBI]
|
1.18531e-05
|
|
|
FCGR2A
|
[NCBI]
|
1.18531e-05
|
|
|
CA4
|
[NCBI]
|
1.18531e-05
|
|
|
EIF2B5
|
[NCBI]
|
1.18531e-05
|
|
|
CEP290
|
[NCBI]
|
1.18531e-05
|
|
|
LDLRAP1
|
[NCBI]
|
1.18531e-05
|
|
|
MSR1
|
[NCBI]
|
1.18531e-05
|
|
|
EN2
|
[NCBI]
|
1.18531e-05
|
|
|
COL9A1
|
[NCBI]
|
1.18531e-05
|
|
|
PDE4D
|
[NCBI]
|
1.18531e-05
|
|
|
MODY1
|
[NCBI]
|
1.14797e-05
|
|
|
CDS
|
[NCBI]
|
1.14797e-05
|
|
|
ISS
|
[NCBI]
|
1.14797e-05
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
1.14797e-05
|
|
|
LGMD1B
|
[NCBI]
|
1.14797e-05
|
|
|
LQT3
|
[NCBI]
|
1.14797e-05
|
|
|
GCCD1
|
[NCBI]
|
1.14797e-05
|
|
|
LGMD2I
|
[NCBI]
|
1.14797e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
1.14797e-05
|
|
|
sitosterolemia
|
[NCBI]
|
1.14797e-05
|
|
|
ARVD1
|
[NCBI]
|
1.14797e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
1.14797e-05
|
|
|
ACHM2
|
[NCBI]
|
1.14797e-05
|
|
|
OPD2
|
[NCBI]
|
1.14797e-05
|
|
|
STGD3
|
[NCBI]
|
1.14797e-05
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
1.14797e-05
|
|
|
FUT1
|
[NCBI]
|
1.1451e-05
|
|
|
TBXA2R
|
[NCBI]
|
1.1451e-05
|
|
|
AHCY
|
[NCBI]
|
1.1451e-05
|
|
|
PRX
|
[NCBI]
|
1.1451e-05
|
|
|
SCN2A
|
[NCBI]
|
1.1451e-05
|
|
|
MTMR2
|
[NCBI]
|
1.1451e-05
|
|
|
NEFH
|
[NCBI]
|
1.1451e-05
|
|
|
CLDN1
|
[NCBI]
|
1.1451e-05
|
|
|
VMD
|
[NCBI]
|
1.13182e-05
|
|
|
LI1
|
[NCBI]
|
1.13182e-05
|
|
|
PDCD1
|
[NCBI]
|
1.10774e-05
|
|
|
DTNBP1
|
[NCBI]
|
1.10774e-05
|
|
|
PDC
|
[NCBI]
|
1.10774e-05
|
|
|
PLAU
|
[NCBI]
|
1.10774e-05
|
|
|
NFATC2
|
[NCBI]
|
1.10774e-05
|
|
|
POMT1
|
[NCBI]
|
1.10774e-05
|
|
|
NAGLU
|
[NCBI]
|
1.10774e-05
|
|
|
OTOF
|
[NCBI]
|
1.10774e-05
|
|
|
MMP13
|
[NCBI]
|
1.10774e-05
|
|
|
ENAM
|
[NCBI]
|
1.10774e-05
|
|
|
LOR
|
[NCBI]
|
1.10774e-05
|
|
|
TULP1
|
[NCBI]
|
1.10774e-05
|
|
|
CCKAR
|
[NCBI]
|
1.10774e-05
|
|
|
ME2
|
[NCBI]
|
1.10774e-05
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
1.08756e-05
|
|
|
DM2
|
[NCBI]
|
1.07793e-05
|
|
|
EDMD
|
[NCBI]
|
1.07793e-05
|
|
|
PMP22
|
[NCBI]
|
1.07464e-05
|
|
|
BMPR1A
|
[NCBI]
|
1.07287e-05
|
|
|
PANK2
|
[NCBI]
|
1.07287e-05
|
|
|
PRKCA
|
[NCBI]
|
1.07287e-05
|
|
|
SGCA
|
[NCBI]
|
1.07287e-05
|
|
|
GABRB3
|
[NCBI]
|
1.07287e-05
|
|
|
COL18A1
|
[NCBI]
|
1.07287e-05
|
|
|
MC3R
|
[NCBI]
|
1.07287e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.07287e-05
|
|
|
CYP2C9
|
[NCBI]
|
1.07287e-05
|
|
|
BEST1
|
[NCBI]
|
1.07287e-05
|
|
|
COL5A1
|
[NCBI]
|
1.07287e-05
|
|
|
KEAP1
|
[NCBI]
|
1.07287e-05
|
|
|
FCGR3A
|
[NCBI]
|
1.07287e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
1.04517e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
1.04517e-05
|
|
|
GAN1
|
[NCBI]
|
1.04517e-05
|
|
|
HPE3
|
[NCBI]
|
1.04517e-05
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
1.04517e-05
|
|
|
PALS
|
[NCBI]
|
1.04517e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
1.04517e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
1.04517e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
1.04517e-05
|
|
|
PPCD1
|
[NCBI]
|
1.04517e-05
|
|
|
HMS1
|
[NCBI]
|
1.04517e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
1.04517e-05
|
|
|
DMD
|
[NCBI]
|
1.04231e-05
|
|
|
CRX
|
[NCBI]
|
1.04018e-05
|
|
|
TAZ
|
[NCBI]
|
1.04018e-05
|
|
|
GABRG2
|
[NCBI]
|
1.04018e-05
|
|
|
RTN4
|
[NCBI]
|
1.04018e-05
|
|
|
CBR1
|
[NCBI]
|
1.04018e-05
|
|
|
MYO6
|
[NCBI]
|
1.04018e-05
|
|
|
SLC16A2
|
[NCBI]
|
1.04018e-05
|
|
|
CYP11A1
|
[NCBI]
|
1.04018e-05
|
|
|
FGB
|
[NCBI]
|
1.04018e-05
|
|
|
GCK
|
[NCBI]
|
1.03235e-05
|
|
|
SCIDX1
|
[NCBI]
|
1.02621e-05
|
|
|
TSHB
|
[NCBI]
|
1.00944e-05
|
|
|
MAPK8IP1
|
[NCBI]
|
1.00944e-05
|
|
|
SURF1
|
[NCBI]
|
1.00944e-05
|
|
|
C5
|
[NCBI]
|
1.00944e-05
|
|
|
FOXC1
|
[NCBI]
|
1.00944e-05
|
|
|
WRN
|
[NCBI]
|
1.00231e-05
|
|
|
KSS
|
[NCBI]
|
9.96014e-06
|
|
|
LEPR
|
[NCBI]
|
9.92587e-06
|
|
|
G6PT1
|
[NCBI]
|
9.80444e-06
|
|
|
PQBP1
|
[NCBI]
|
9.80444e-06
|
|
|
SGCE
|
[NCBI]
|
9.80444e-06
|
|
|
FRAXE
|
[NCBI]
|
9.80444e-06
|
|
|
COL11A2
|
[NCBI]
|
9.80444e-06
|
|
|
FGF3
|
[NCBI]
|
9.80444e-06
|
|
|
PRKCG
|
[NCBI]
|
9.80444e-06
|
|
|
IL9
|
[NCBI]
|
9.80444e-06
|
|
|
ADRB3
|
[NCBI]
|
9.80444e-06
|
|
|
LWD
|
[NCBI]
|
9.76554e-06
|
|
|
RP
|
[NCBI]
|
9.59366e-06
|
|
|
GALK1
|
[NCBI]
|
9.53016e-06
|
|
|
CACNA1S
|
[NCBI]
|
9.53016e-06
|
|
|
C9
|
[NCBI]
|
9.53016e-06
|
|
|
AMY1A
|
[NCBI]
|
9.53016e-06
|
|
|
NNMT
|
[NCBI]
|
9.53016e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
9.53016e-06
|
|
|
AMELX
|
[NCBI]
|
9.53016e-06
|
|
|
NEB
|
[NCBI]
|
9.53016e-06
|
|
|
NFATC1
|
[NCBI]
|
9.53016e-06
|
|
|
NCSTN
|
[NCBI]
|
9.53016e-06
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
9.51926e-06
|
|
|
PFM
|
[NCBI]
|
9.51926e-06
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
9.51926e-06
|
|
|
VED
|
[NCBI]
|
9.51926e-06
|
|
|
coumarin resistance
|
[NCBI]
|
9.51926e-06
|
|
|
hartnup disorder
|
[NCBI]
|
9.51926e-06
|
|
|
HSAN2
|
[NCBI]
|
9.51926e-06
|
|
|
PARK6
|
[NCBI]
|
9.51926e-06
|
|
|
TYR
|
[NCBI]
|
9.45603e-06
|
|
|
CUBN
|
[NCBI]
|
9.27005e-06
|
|
|
DRD3
|
[NCBI]
|
9.27005e-06
|
|
|
ITGB1
|
[NCBI]
|
9.27005e-06
|
|
|
PEX7
|
[NCBI]
|
9.27005e-06
|
|
|
CLCN5
|
[NCBI]
|
9.27005e-06
|
|
|
GJB6
|
[NCBI]
|
9.27005e-06
|
|
|
DSP
|
[NCBI]
|
9.27005e-06
|
|
|
GPR54
|
[NCBI]
|
9.27005e-06
|
|
|
KRT1
|
[NCBI]
|
9.02284e-06
|
|
|
CPM
|
[NCBI]
|
9.02284e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
9.02284e-06
|
|
|
EBP
|
[NCBI]
|
9.02284e-06
|
|
|
CAPN10
|
[NCBI]
|
8.78739e-06
|
|
|
RPS6KA5
|
[NCBI]
|
8.78739e-06
|
|
|
VAMP2
|
[NCBI]
|
8.78739e-06
|
|
|
AACT
|
[NCBI]
|
8.78739e-06
|
|
|
NR3C2
|
[NCBI]
|
8.78739e-06
|
|
|
APTX
|
[NCBI]
|
8.78739e-06
|
|
|
CYP1B1
|
[NCBI]
|
8.78739e-06
|
|
|
SHH
|
[NCBI]
|
8.71297e-06
|
|
|
refsum disease
|
[NCBI]
|
8.6705e-06
|
|
|
DYT3
|
[NCBI]
|
8.6705e-06
|
|
|
RSMD1
|
[NCBI]
|
8.6705e-06
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
8.6705e-06
|
|
|
CORD2
|
[NCBI]
|
8.6705e-06
|
|
|
NPHS1
|
[NCBI]
|
8.6705e-06
|
|
|
EDC
|
[NCBI]
|
8.6705e-06
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
8.6705e-06
|
|
|
CIPA
|
[NCBI]
|
8.6705e-06
|
|
|
EV
|
[NCBI]
|
8.59083e-06
|
|
|
CDSN
|
[NCBI]
|
8.56273e-06
|
|
|
TRAF6
|
[NCBI]
|
8.56273e-06
|
|
|
EMD
|
[NCBI]
|
8.56273e-06
|
|
|
SLC17A6
|
[NCBI]
|
8.56273e-06
|
|
|
PPARA
|
[NCBI]
|
8.52363e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
8.45871e-06
|
|
|
EGR2
|
[NCBI]
|
8.348e-06
|
|
|
MYH9
|
[NCBI]
|
8.348e-06
|
|
|
HLA-DRB1
|
[NCBI]
|
8.348e-06
|
|
|
LRP5
|
[NCBI]
|
8.348e-06
|
|
|
BCNS
|
[NCBI]
|
8.34578e-06
|
|
|
EXT1
|
[NCBI]
|
8.14243e-06
|
|
|
SLN
|
[NCBI]
|
8.14243e-06
|
|
|
NRAS
|
[NCBI]
|
8.14243e-06
|
|
|
RBP3
|
[NCBI]
|
8.14243e-06
|
|
|
CDKN1C
|
[NCBI]
|
8.14243e-06
|
|
|
CACNA1C
|
[NCBI]
|
8.14243e-06
|
|
|
BMP4
|
[NCBI]
|
8.1259e-06
|
|
|
TH
|
[NCBI]
|
8.04078e-06
|
|
|
CFH
|
[NCBI]
|
7.9758e-06
|
|
|
AMC
|
[NCBI]
|
7.96928e-06
|
|
|
SLC22A5
|
[NCBI]
|
7.94533e-06
|
|
|
ATXN8OS
|
[NCBI]
|
7.94533e-06
|
|
|
EYA1
|
[NCBI]
|
7.94533e-06
|
|
|
MVK
|
[NCBI]
|
7.94533e-06
|
|
|
GJB1
|
[NCBI]
|
7.90196e-06
|
|
|
camurati-engelmann disease
|
[NCBI]
|
7.89554e-06
|
|
|
OFD1
|
[NCBI]
|
7.89554e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
7.89554e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
7.89554e-06
|
|
|
FTLDU
|
[NCBI]
|
7.89554e-06
|
|
|
AICDA
|
[NCBI]
|
7.75612e-06
|
|
|
MYCN
|
[NCBI]
|
7.75612e-06
|
|
|
PRG4
|
[NCBI]
|
7.75612e-06
|
|
|
AHR
|
[NCBI]
|
7.72386e-06
|
|
|
PITX2
|
[NCBI]
|
7.57423e-06
|
|
|
FABP2
|
[NCBI]
|
7.57423e-06
|
|
|
SLC25A4
|
[NCBI]
|
7.57423e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
7.57423e-06
|
|
|
PRSS1
|
[NCBI]
|
7.57423e-06
|
|
|
WS1
|
[NCBI]
|
7.5638e-06
|
|
|
MITF
|
[NCBI]
|
7.47498e-06
|
|
|
TTN
|
[NCBI]
|
7.39919e-06
|
|
|
NOS2A
|
[NCBI]
|
7.39919e-06
|
|
|
COL4A5
|
[NCBI]
|
7.23055e-06
|
|
|
CD40LG
|
[NCBI]
|
7.23055e-06
|
|
|
TGFBR2
|
[NCBI]
|
7.23055e-06
|
|
|
PRODH
|
[NCBI]
|
7.23055e-06
|
|
|
KCNJ11
|
[NCBI]
|
7.23055e-06
|
|
|
CST3
|
[NCBI]
|
7.23055e-06
|
|
|
CLN2
|
[NCBI]
|
7.18616e-06
|
|
|
VWM
|
[NCBI]
|
7.18616e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
7.18616e-06
|
|
|
HIDS
|
[NCBI]
|
7.18616e-06
|
|
|
ACLS
|
[NCBI]
|
7.18616e-06
|
|
|
pancreatic carcinoma
|
[NCBI]
|
7.18616e-06
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
7.18616e-06
|
|
|
AIED
|
[NCBI]
|
7.18616e-06
|
|
|
ESCS
|
[NCBI]
|
7.18616e-06
|
|
|
bethlem myopathy
|
[NCBI]
|
7.18616e-06
|
|
|
APS1
|
[NCBI]
|
7.13509e-06
|
|
|
IGF1R
|
[NCBI]
|
7.0679e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
7.0679e-06
|
|
|
GLI3
|
[NCBI]
|
7.0679e-06
|
|
|
CAPN3
|
[NCBI]
|
7.0679e-06
|
|
|
ALDH3A2
|
[NCBI]
|
7.0679e-06
|
|
|
COL6A1
|
[NCBI]
|
7.0679e-06
|
|
|
ALPL
|
[NCBI]
|
7.0679e-06
|
|
|
CRY1
|
[NCBI]
|
7.0679e-06
|
|
|
IL1A
|
[NCBI]
|
7.0679e-06
|
|
|
SLC40A1
|
[NCBI]
|
7.0679e-06
|
|
|
GCH1
|
[NCBI]
|
7.0679e-06
|
|
|
SMAD4
|
[NCBI]
|
7.0679e-06
|
|
|
MAOB
|
[NCBI]
|
6.9109e-06
|
|
|
oca2 gene
|
[NCBI]
|
6.9109e-06
|
|
|
IL5
|
[NCBI]
|
6.7592e-06
|
|
|
SAA1
|
[NCBI]
|
6.7592e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
6.6125e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
6.53546e-06
|
|
|
DA2A
|
[NCBI]
|
6.53546e-06
|
|
|
PARK8
|
[NCBI]
|
6.53546e-06
|
|
|
masa syndrome
|
[NCBI]
|
6.53546e-06
|
|
|
AAA
|
[NCBI]
|
6.53546e-06
|
|
|
PLOSL
|
[NCBI]
|
6.53546e-06
|
|
|
KTCN1
|
[NCBI]
|
6.53546e-06
|
|
|
MEN2B
|
[NCBI]
|
6.53546e-06
|
|
|
CYP2A6
|
[NCBI]
|
6.47052e-06
|
|
|
ICAM1
|
[NCBI]
|
6.47052e-06
|
|
|
CHM
|
[NCBI]
|
6.44114e-06
|
|
|
AUTS9
|
[NCBI]
|
6.37309e-06
|
|
|
THAS
|
[NCBI]
|
6.37309e-06
|
|
|
gastroesophageal reflux
|
[NCBI]
|
6.37309e-06
|
|
|
GAPDH
|
[NCBI]
|
6.35199e-06
|
|
|
AVPR2
|
[NCBI]
|
6.33302e-06
|
|
|
ACP1
|
[NCBI]
|
6.33302e-06
|
|
|
NDP
|
[NCBI]
|
6.33302e-06
|
|
|
RPS6KA3
|
[NCBI]
|
6.33302e-06
|
|
|
LTA
|
[NCBI]
|
6.19974e-06
|
|
|
FN1
|
[NCBI]
|
6.19974e-06
|
|
|
GK
|
[NCBI]
|
6.19974e-06
|
|
|
MCKD1
|
[NCBI]
|
6.09109e-06
|
|
|
PDE6B
|
[NCBI]
|
6.07049e-06
|
|
|
SHOX
|
[NCBI]
|
6.07049e-06
|
|
|
PTPRC
|
[NCBI]
|
6.07049e-06
|
|
|
MECP2
|
[NCBI]
|
6.05847e-06
|
|
|
OPMD
|
[NCBI]
|
6.0373e-06
|
|
|
FMF
|
[NCBI]
|
5.95133e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
5.94504e-06
|
|
|
EDNRB
|
[NCBI]
|
5.94504e-06
|
|
|
CGL2
|
[NCBI]
|
5.93756e-06
|
|
|
EDMD2
|
[NCBI]
|
5.93756e-06
|
|
|
MNGIE
|
[NCBI]
|
5.93756e-06
|
|
|
CCAL2
|
[NCBI]
|
5.93756e-06
|
|
|
UCMD
|
[NCBI]
|
5.93756e-06
|
|
|
pfeiffer syndrome
|
[NCBI]
|
5.93756e-06
|
|
|
SCA17
|
[NCBI]
|
5.93756e-06
|
|
|
STK11
|
[NCBI]
|
5.82323e-06
|
|
|
UMOD
|
[NCBI]
|
5.82323e-06
|
|
|
fucosidosis
|
[NCBI]
|
5.82323e-06
|
|
|
MYH11
|
[NCBI]
|
5.82323e-06
|
|
|
GRN
|
[NCBI]
|
5.82323e-06
|
|
|
ABCA4
|
[NCBI]
|
5.58981e-06
|
|
|
CASR
|
[NCBI]
|
5.53326e-06
|
|
|
ADIPOQ
|
[NCBI]
|
5.47789e-06
|
|
|
LPA
|
[NCBI]
|
5.47789e-06
|
|
|
CHAC
|
[NCBI]
|
5.38742e-06
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
5.38742e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
5.38742e-06
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
5.38742e-06
|
|
|
PPH1
|
[NCBI]
|
5.38742e-06
|
|
|
UOX
|
[NCBI]
|
5.38742e-06
|
|
|
POLG
|
[NCBI]
|
5.36898e-06
|
|
|
CYP17A1
|
[NCBI]
|
5.36898e-06
|
|
|
SLC6A3
|
[NCBI]
|
5.36629e-06
|
|
|
KAL1
|
[NCBI]
|
5.26294e-06
|
|
|
RELN
|
[NCBI]
|
5.15966e-06
|
|
|
VLDLR
|
[NCBI]
|
5.15966e-06
|
|
|
ABCA1
|
[NCBI]
|
5.05901e-06
|
|
|
L1CAM
|
[NCBI]
|
5.05901e-06
|
|
|
DCT
|
[NCBI]
|
5.05901e-06
|
|
|
CTSC
|
[NCBI]
|
5.05901e-06
|
|
|
TSC1
|
[NCBI]
|
5.05901e-06
|
|
|
HBG2
|
[NCBI]
|
4.9609e-06
|
|
|
EKV
|
[NCBI]
|
4.88069e-06
|
|
|
CHNG2
|
[NCBI]
|
4.88069e-06
|
|
|
DRD
|
[NCBI]
|
4.88069e-06
|
|
|
hodgkin lymphoma
|
[NCBI]
|
4.88069e-06
|
|
|
FFI
|
[NCBI]
|
4.8684e-06
|
|
|
CDLS1
|
[NCBI]
|
4.8684e-06
|
|
|
COL3A1
|
[NCBI]
|
4.86521e-06
|
|
|
TCOF
|
[NCBI]
|
4.84928e-06
|
|
|
WT1
|
[NCBI]
|
4.68152e-06
|
|
|
DAO
|
[NCBI]
|
4.68075e-06
|
|
|
HS
|
[NCBI]
|
4.68075e-06
|
|
|
ADHD
|
[NCBI]
|
4.6714e-06
|
|
|
SCN5A
|
[NCBI]
|
4.5918e-06
|
|
|
PSAP
|
[NCBI]
|
4.5918e-06
|
|
|
CYP2D6
|
[NCBI]
|
4.5918e-06
|
|
|
FLNA
|
[NCBI]
|
4.50493e-06
|
|
|
RLBP1
|
[NCBI]
|
4.50493e-06
|
|
|
LHCGR
|
[NCBI]
|
4.42006e-06
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
4.41361e-06
|
|
|
SCDO1
|
[NCBI]
|
4.41361e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
4.41361e-06
|
|
|
HOKPP
|
[NCBI]
|
4.41361e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
4.41361e-06
|
|
|
GJA1
|
[NCBI]
|
4.32497e-06
|
|
|
fabry disease
|
[NCBI]
|
4.315e-06
|
|
|
PGM1
|
[NCBI]
|
4.25605e-06
|
|
|
TG
|
[NCBI]
|
4.14006e-06
|
|
|
COMT
|
[NCBI]
|
4.11e-06
|
|
|
SLC2A2
|
[NCBI]
|
4.09925e-06
|
|
|
SVAS
|
[NCBI]
|
4.04093e-06
|
|
|
TPO
|
[NCBI]
|
4.00021e-06
|
|
|
CFNS
|
[NCBI]
|
3.98286e-06
|
|
|
citrullinemia, classic
|
[NCBI]
|
3.98286e-06
|
|
|
ODDD
|
[NCBI]
|
3.98286e-06
|
|
|
SEDC
|
[NCBI]
|
3.98286e-06
|
|
|
MRXHF1
|
[NCBI]
|
3.98286e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
3.98286e-06
|
|
|
NEM3
|
[NCBI]
|
3.98286e-06
|
|
|
ENPEP
|
[NCBI]
|
3.94917e-06
|
|
|
KCNQ1
|
[NCBI]
|
3.94917e-06
|
|
|
NOS3
|
[NCBI]
|
3.87652e-06
|
|
|
HRAS
|
[NCBI]
|
3.87652e-06
|
|
|
CHS
|
[NCBI]
|
3.846e-06
|
|
|
NF2
|
[NCBI]
|
3.80539e-06
|
|
|
ITGB3
|
[NCBI]
|
3.80539e-06
|
|
|
DHS
|
[NCBI]
|
3.80098e-06
|
|
|
IGAN1
|
[NCBI]
|
3.80098e-06
|
|
|
SHFM3
|
[NCBI]
|
3.80098e-06
|
|
|
MMP2
|
[NCBI]
|
3.73574e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.68603e-06
|
|
|
UGT1A1
|
[NCBI]
|
3.66751e-06
|
|
|
IRS1
|
[NCBI]
|
3.66751e-06
|
|
|
VDR
|
[NCBI]
|
3.64387e-06
|
|
|
FSHMD1A
|
[NCBI]
|
3.60172e-06
|
|
|
FOXP3
|
[NCBI]
|
3.60068e-06
|
|
|
lung cancer
|
[NCBI]
|
3.58553e-06
|
|
|
LCA1
|
[NCBI]
|
3.58553e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
3.58553e-06
|
|
|
ALMS
|
[NCBI]
|
3.58553e-06
|
|
|
TGFB1
|
[NCBI]
|
3.53519e-06
|
|
|
NOTCH1
|
[NCBI]
|
3.53519e-06
|
|
|
LPL
|
[NCBI]
|
3.49987e-06
|
|
|
GCCR
|
[NCBI]
|
3.47101e-06
|
|
|
CCR5
|
[NCBI]
|
3.28592e-06
|
|
|
DRPLA
|
[NCBI]
|
3.25153e-06
|
|
|
OPTB1
|
[NCBI]
|
3.21906e-06
|
|
|
EVC
|
[NCBI]
|
3.21906e-06
|
|
|
OKS
|
[NCBI]
|
3.21906e-06
|
|
|
TSC2
|
[NCBI]
|
3.16841e-06
|
|
|
MC4R
|
[NCBI]
|
3.16841e-06
|
|
|
DRD4
|
[NCBI]
|
3.16841e-06
|
|
|
IP
|
[NCBI]
|
3.16451e-06
|
|
|
NR0B2
|
[NCBI]
|
3.11132e-06
|
|
|
THRB
|
[NCBI]
|
3.11132e-06
|
|
|
TS
|
[NCBI]
|
3.06324e-06
|
|
|
SLC4A1
|
[NCBI]
|
3.0553e-06
|
|
|
PAX6
|
[NCBI]
|
3.00033e-06
|
|
|
PARK2
|
[NCBI]
|
2.94637e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
2.90503e-06
|
|
|
TFPI
|
[NCBI]
|
2.90309e-06
|
|
|
PARP1
|
[NCBI]
|
2.89341e-06
|
|
|
neural tube defects
|
[NCBI]
|
2.88115e-06
|
|
|
BOR1
|
[NCBI]
|
2.88115e-06
|
|
|
PLG
|
[NCBI]
|
2.86289e-06
|
|
|
BMP2
|
[NCBI]
|
2.84141e-06
|
|
|
TSHR
|
[NCBI]
|
2.79035e-06
|
|
|
PXE
|
[NCBI]
|
2.70047e-06
|
|
|
RB1
|
[NCBI]
|
2.67379e-06
|
|
|
STGD1
|
[NCBI]
|
2.56977e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
2.56977e-06
|
|
|
testicular tumors
|
[NCBI]
|
2.56977e-06
|
|
|
ETL2
|
[NCBI]
|
2.53959e-06
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
2.53959e-06
|
|
|
BLM
|
[NCBI]
|
2.49168e-06
|
|
|
LS
|
[NCBI]
|
2.49168e-06
|
|
|
PLN
|
[NCBI]
|
2.45746e-06
|
|
|
LCT
|
[NCBI]
|
2.41317e-06
|
|
|
SPP1
|
[NCBI]
|
2.3981e-06
|
|
|
GBA
|
[NCBI]
|
2.28477e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
2.28308e-06
|
|
|
DKC
|
[NCBI]
|
2.28308e-06
|
|
|
MCOPS7
|
[NCBI]
|
2.28308e-06
|
|
|
ALB
|
[NCBI]
|
2.24445e-06
|
|
|
COL2A1
|
[NCBI]
|
2.20275e-06
|
|
|
FGF1
|
[NCBI]
|
2.0848e-06
|
|
|
CPI
|
[NCBI]
|
2.02005e-06
|
|
|
BCPM
|
[NCBI]
|
2.01944e-06
|
|
|
PD
|
[NCBI]
|
2.00836e-06
|
|
|
PMD
|
[NCBI]
|
1.92341e-06
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
1.89812e-06
|
|
|
CDB2
|
[NCBI]
|
1.89812e-06
|
|
|
breast cancer
|
[NCBI]
|
1.84376e-06
|
|
|
HP
|
[NCBI]
|
1.82425e-06
|
|
|
VIM
|
[NCBI]
|
1.76412e-06
|
|
|
GNAS
|
[NCBI]
|
1.73131e-06
|
|
|
PJS
|
[NCBI]
|
1.71417e-06
|
|
|
CCD
|
[NCBI]
|
1.6953e-06
|
|
|
CPB2
|
[NCBI]
|
1.66725e-06
|
|
|
PIGR
|
[NCBI]
|
1.63598e-06
|
|
|
NRG1
|
[NCBI]
|
1.57493e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
1.55548e-06
|
|
|
SMA1
|
[NCBI]
|
1.55436e-06
|
|
|
FGF7
|
[NCBI]
|
1.52676e-06
|
|
|
PCI
|
[NCBI]
|
1.51578e-06
|
|
|
MAOA
|
[NCBI]
|
1.48691e-06
|
|
|
ACE
|
[NCBI]
|
1.4284e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.40871e-06
|
|
|
ABCC8
|
[NCBI]
|
1.37588e-06
|
|
|
EVA
|
[NCBI]
|
1.3526e-06
|
|
|
PAM
|
[NCBI]
|
1.3492e-06
|
|
|
ESR1
|
[NCBI]
|
1.32294e-06
|
|
|
TF
|
[NCBI]
|
1.31208e-06
|
|
|
NS1
|
[NCBI]
|
1.29427e-06
|
|
|
ATM
|
[NCBI]
|
1.27163e-06
|
|
|
MAPT
|
[NCBI]
|
1.17373e-06
|
|
|
SPINK1
|
[NCBI]
|
1.17373e-06
|
|
|
OCA2
|
[NCBI]
|
1.16758e-06
|
|
|
MM
|
[NCBI]
|
1.16758e-06
|
|
|
CADASIL
|
[NCBI]
|
1.16758e-06
|
|
|
PCTT
|
[NCBI]
|
1.16758e-06
|
|
|
von willebrand disease
|
[NCBI]
|
1.10424e-06
|
|
|
CP
|
[NCBI]
|
1.07412e-06
|
|
|
LRP1
|
[NCBI]
|
1.00789e-06
|
|
|
FIH
|
[NCBI]
|
9.99418e-07
|
|
|
SMA3
|
[NCBI]
|
9.99418e-07
|
|
|
GCPS
|
[NCBI]
|
9.99418e-07
|
|
|
malaria, susceptibility to
|
[NCBI]
|
9.99418e-07
|
|
|
kartagener syndrome
|
[NCBI]
|
9.99418e-07
|
|
|
WFS1
|
[NCBI]
|
9.99418e-07
|
|
|
RET
|
[NCBI]
|
9.95437e-07
|
|
|
FGFR1
|
[NCBI]
|
9.74684e-07
|
|
|
GTS
|
[NCBI]
|
9.2785e-07
|
|
|
DDC
|
[NCBI]
|
9.14351e-07
|
|
|
CD
|
[NCBI]
|
8.89841e-07
|
|
|
LCAT
|
[NCBI]
|
8.8366e-07
|
|
|
KDR
|
[NCBI]
|
8.75688e-07
|
|
|
PCD
|
[NCBI]
|
8.57516e-07
|
|
|
wilson disease
|
[NCBI]
|
8.5605e-07
|
|
|
TBP
|
[NCBI]
|
8.19944e-07
|
|
|
DMD
|
[NCBI]
|
8.19235e-07
|
|
|
PON1
|
[NCBI]
|
7.32768e-07
|
|
|
BGLAP
|
[NCBI]
|
7.16157e-07
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
7.09964e-07
|
|
|
PDS
|
[NCBI]
|
7.09964e-07
|
|
|
CTNS
|
[NCBI]
|
7.09964e-07
|
|
|
mucolipidosis ii
|
[NCBI]
|
7.09964e-07
|
|
|
HMBS
|
[NCBI]
|
6.83731e-07
|
|
|
NGFR
|
[NCBI]
|
6.52342e-07
|
|
|
FGF2
|
[NCBI]
|
6.07145e-07
|
|
|
TRPS2
|
[NCBI]
|
5.87024e-07
|
|
|
HHF1
|
[NCBI]
|
5.87024e-07
|
|
|
SLC2A4
|
[NCBI]
|
5.50271e-07
|
|
|
TD1
|
[NCBI]
|
5.04444e-07
|
|
|
GIP
|
[NCBI]
|
4.87116e-07
|
|
|
ACADM
|
[NCBI]
|
4.84358e-07
|
|
|
PLTP
|
[NCBI]
|
4.84358e-07
|
|
|
AUTS6
|
[NCBI]
|
4.45698e-07
|
|
|
PSEN1
|
[NCBI]
|
4.35557e-07
|
|
|
FTD
|
[NCBI]
|
3.83742e-07
|
|
|
CDSP
|
[NCBI]
|
3.81053e-07
|
|
|
WAS
|
[NCBI]
|
2.75483e-07
|
|
|
HEMB
|
[NCBI]
|
2.72046e-07
|
|
|
LDLR
|
[NCBI]
|
2.68834e-07
|
|
|
PMCH
|
[NCBI]
|
2.63047e-07
|
|
|
MBL2
|
[NCBI]
|
2.40422e-07
|
|
|
IHH
|
[NCBI]
|
2.38409e-07
|
|
|
HOS
|
[NCBI]
|
2.3397e-07
|
|
|
HFE
|
[NCBI]
|
2.30419e-07
|
|
|
XPA
|
[NCBI]
|
2.2403e-07
|
|
|
OXT
|
[NCBI]
|
2.07425e-07
|
|
|
VUR1
|
[NCBI]
|
2.03719e-07
|
|
|
PEDF
|
[NCBI]
|
1.72261e-07
|
|
|
SST
|
[NCBI]
|
1.65687e-07
|
|
|
ABL
|
[NCBI]
|
1.62442e-07
|
|
|
EPOR
|
[NCBI]
|
1.59264e-07
|
|
|
BPES
|
[NCBI]
|
1.34348e-07
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.27356e-07
|
|
|
DYT1
|
[NCBI]
|
1.11452e-07
|
|
|
ALGS1
|
[NCBI]
|
1.11452e-07
|
|
|
aortic valve disease
|
[NCBI]
|
1.11452e-07
|
|
|
SHFLD1
|
[NCBI]
|
1.01723e-07
|
|
|
WM1
|
[NCBI]
|
1.01723e-07
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
1.01723e-07
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
1.01723e-07
|
|
|
TOC
|
[NCBI]
|
1.01723e-07
|
|
|
SLS
|
[NCBI]
|
9.41898e-08
|
|
|
COMP
|
[NCBI]
|
9.33253e-08
|
|
|
MUC1
|
[NCBI]
|
7.39986e-08
|
|
|
PI
|
[NCBI]
|
5.86269e-08
|
|
|
FMR1
|
[NCBI]
|
5.29913e-08
|
|
|
KCNH2
|
[NCBI]
|
4.96378e-08
|
|
|
PNMT
|
[NCBI]
|
4.72194e-08
|
|
|
MTM1
|
[NCBI]
|
3.43858e-08
|
|
|
ED1
|
[NCBI]
|
3.43858e-08
|
|
|
TLR2
|
[NCBI]
|
3.19837e-08
|
|
|
DBA
|
[NCBI]
|
1.98428e-08
|
|
|
GHR
|
[NCBI]
|
1.82251e-08
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.75095e-08
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
1.52638e-08
|
|
|
HHT
|
[NCBI]
|
4.49548e-09
|
|
|
HNPP
|
[NCBI]
|
4.49548e-09
|
|
|
FGFR3
|
[NCBI]
|
4.01085e-09
|
|
|
CLS
|
[NCBI]
|
3.70348e-09
|
|
|
SERPINA6
|
[NCBI]
|
1.88729e-09
|
|
|
POMC
|
[NCBI]
|
3.09122e-11
|
|
|
HHF2
|
[NCBI]
|
7.10539e-12
|
|
|
AN2
|
[NCBI]
|
7.10539e-12
|
|